col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

971 Results       Page 1

Springer Science and Business Media LLC: Nature Communications
  original article Date Title Authors   All Authors
1 [GO] 2023―Sep―18 Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection Tomalika R. Ullah, Matt D. Johansen, Katherine R. Balka, Rebecca L. Ambrose, Linden J. Gearing, James Roest, et al. (+27)
2 [GO] 2023―Sep―18 Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation Qi Zhang, Weichun Tang, Eduardo Stancanelli, Eunkyung Jung, Zulfeqhar Syed, Vijayakanth Pagadala, et al. (+12)
3 [GO] 2023―Sep―13 Author Correction: National surveillance data analysis of COVID-19 vaccine uptake in England by women of reproductive age Laura A. Magee, Erika Molteni, Vicky Bowyer, Jeffrey N. Bone, Harriet Boulding, Asma Khalil, et al. (+17)
4 [GO] 2023―Sep―13 Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets Filip Mihalič, Caroline Benz, Eszter Kassa, Richard Lindqvist, Leandro Simonetti, Raviteja Inturi, et al. (+7)
5 [GO] 2023―Sep―12 Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk Laura Pérez-Alós, Cecilie Bo Hansen, Jose Juan Almagro Armenteros, Johannes Roth Madsen, Line Dam Heftdal, Rasmus Bo Hasselbalch, et al. (+13)
6 [GO] 2023―Sep―12 The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease Norman Tran, Sathish Dasari, Sarah A. E. Barwell, Matthew J. McLeod, Subha Kalyaanamoorthy, Todd Holyoak, Aravindhan Ganesan
7 [GO] 2023―Sep―08 Panoramic analysis of coronaviruses carried by representative bat species in Southern China to better understand the coronavirus sphere Yelin Han, Panpan Xu, Yuyang Wang, Wenliang Zhao, Junpeng Zhang, Shuyi Zhang, et al. (+3)
8 [GO] 2023―Sep―06 Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection Denis Mongin, Nils Bürgisser, Gustavo Laurie, Guillaume Schimmel, Diem-Lan Vu, Stephane Cullati, et al. (+38)
9 [GO] 2023―Aug―29 Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study Laura Lindsay, Clara Calvert, Ting Shi, Jade Carruthers, Cheryl Denny, Jack Donaghy, et al. (+15)
10 [GO] 2023―Aug―29 Effects of public-health measures for zeroing out different SARS-CoV-2 variants Yong Ge, Xilin Wu, Wenbin Zhang, Xiaoli Wang, Die Zhang, Jianghao Wang, et al. (+11)
11 [GO] 2023―Aug―28 Accelerated evolution of SARS-CoV-2 in free-ranging white-tailed deer Dillon S. McBride, Sofya K. Garushyants, John Franks, Andrew F. Magee, Steven H. Overend, Devra Huey, et al. (+23)
12 [GO] 2023―Aug―26 Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography Annika Rössler, Antonia Netzl, Ludwig Knabl, David Bante, Samuel H. Wilks, Wegene Borena, et al. (+3)
13 [GO] 2023―Aug―25 An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants Juan Liu, Fengfeng Mao, Jianhe Chen, Shuaiyao Lu, Yonghe Qi, Yinyan Sun, et al. (+33)
14 [GO] 2023―Aug―24 SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations Andrew P. Hederman, Harini Natarajan, Leo Heyndrickx, Kevin K. Ariën, Joshua A. Wiener, Peter F. Wright, et al. (+10)
15 [GO] 2023―Aug―23 Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity Daniel M. Altmann, Catherine J. Reynolds, George Joy, Ashley D. Otter, Joseph M. Gibbons, Corinna Pade, et al. (+10)
16 [GO] 2023―Aug―23 Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, Stephen R. Walsh, Brandon Essink, Adam Brosz, et al. (+11)
17 [GO] 2023―Aug―21 CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis Zihan Tang, Yanyan Xu, Yun Tan, Hui Shi, Peipei Jin, Yunqi Li, et al. (+19)
18 [GO] 2023―Aug―19 Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population Margaret L. Lind, Murilo Dorion, Amy J. Houde, Mary Lansing, Sarah Lapidus, Russell Thomas, et al. (+9)
19 [GO] 2023―Aug―18 Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne M. Rittig, et al. (+31)
20 [GO] 2023―Aug―18 Attaching protein-adsorbing silica particles to the surface of cotton substrates for bioaerosol capture including SARS-CoV-2 Kieran Collings, Cedric Boisdon, Tung-Ting Sham, Kevin Skinley, Hyun-Kyung Oh, Tessa Prince, et al. (+9)
21 [GO] 2023―Aug―16 SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people Matthew Whitaker, Bethan Davies, Christina Atchison, Wendy Barclay, Deborah Ashby, Ara Darzi, et al. (+6)
22 [GO] 2023―Aug―15 Inequalities in COVID-19 severe morbidity and mortality by country of birth in Sweden Mikael Rostila, Agneta Cederström, Matthew Wallace, Siddartha Aradhya, Malin Ahrne, Sol P. Juárez
23 [GO] 2023―Aug―11 Elevated binding and functional antibody responses to SARS-CoV-2 in infants versus mothers Caitlin I. Stoddard, Kevin Sung, Zak A. Yaffe, Haidyn Weight, Guillaume Beaudoin-Bussières, Jared Galloway, et al. (+11)
24 [GO] 2023―Aug―10 Genomic epidemiology offers high resolution estimates of serial intervals for COVID-19 Jessica E. Stockdale, Kurnia Susvitasari, Paul Tupper, Benjamin Sobkowiak, Nicola Mulberry, Anders Gonçalves da Silva, et al. (+6)
25 [GO] 2023―Aug―10 SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates Elisabeth A. Murphy, Camila Guzman-Cardozo, Ashley C. Sukhu, Debby J. Parks, Malavika Prabhu, Iman Mohammed, et al. (+12)
26 [GO] 2023―Aug―09 Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology Brechje de Gier, Anne J. Huiberts, Christina E. Hoeve, Gerco den Hartog, Henri van Werkhoven, Rob van Binnendijk, et al. (+4)
27 [GO] 2023―Aug―08 Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults Hangjie Zhang, Nani Xu, Yu Xu, Pan Qin, Rongrong Dai, Bicheng Xu, et al. (+10)
28 [GO] 2023―Aug―07 Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models Robert M. Cox, Carolin M. Lieber, Josef D. Wolf, Amirhossein Karimi, Nicole A. P. Lieberman, Zachary M. Sticher, et al. (+8)
29 [GO] 2023―Aug―03 Genetic risk, adherence to healthy lifestyle and acute cardiovascular and thromboembolic complications following SARS-COV-2 infection Junqing Xie, Yuliang Feng, Danielle Newby, Bang Zheng, Qi Feng, Albert Prats-Uribe, et al. (+4)
30 [GO] 2023―Jul―29 Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2 Tomer Hertz, Shlomia Levy, Daniel Ostrovsky, Hanna Oppenheimer, Shosh Zismanov, Alona Kuzmina, et al. (+21)
31 [GO] 2023―Jul―28 Monoclonal antibody levels and protection from COVID-19 Eva Stadler, Martin T. Burgess, Timothy E. Schlub, Shanchita R. Khan, Khai Li Chai, Zoe K. McQuilten, et al. (+6)
32 [GO] 2023―Jul―28 Wastewater-based epidemiology predicts COVID-19-induced weekly new hospital admissions in over 150 USA counties Xuan Li, Huan Liu, Li Gao, Samendra P. Sherchan, Ting Zhou, Stuart J. Khan, et al. (+2)
33 [GO] 2023―Jul―28 Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults Karina A. Pasquevich, Lorena M. Coria, Ana Ceballos, Bianca Mazzitelli, Juan Manuel Rodriguez, Agostina Demaría, et al. (+34)
34 [GO] 2023―Jul―26 Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants Guilherme Dias de Melo, Victoire Perraud, Flavio Alvarez, Alba Vieites-Prado, Seonhee Kim, Lauriane Kergoat, et al. (+16)
35 [GO] 2023―Jul―25 Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19 Shelly J. Robertson, Olivia Bedard, Kristin L. McNally, Carl Shaia, Chad S. Clancy, Matthew Lewis, et al. (+23)
36 [GO] 2023―Jul―19 Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach Alexandra B. Hogan, Patrick Doohan, Sean L. Wu, Daniela Olivera Mesa, Jaspreet Toor, Oliver J. Watson, et al. (+7)
37 [GO] 2023―Jul―17 Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England Pablo N. Perez-Guzman, Edward Knock, Natsuko Imai, Thomas Rawson, Yasin Elmaci, Joana Alcada, et al. (+11)
38 [GO] 2023―Jul―17 Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters Rafael R. G. Machado, Jordyn L. Walker, Dionna Scharton, Grace H. Rafael, Brooke M. Mitchell, Rachel A. Reyna, et al. (+6)
39 [GO] 2023―Jul―15 Long-term neurological outcome after COVID-19 using all SARS-CoV-2 test results and hospitalisations in Denmark with 22-month follow-up Clara S. Grønkjær, Rune H. B. Christensen, Daniel Kondziella, Michael E. Benros
40 [GO] 2023―Jul―15 In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir Maki Kiso, Seiya Yamayoshi, Shun Iida, Yuri Furusawa, Yuichiro Hirata, Ryuta Uraki, et al. (+3)
41 [GO] 2023―Jul―14 Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants Saya Moriyama, Yuki Anraku, Shunta Taminishi, Yu Adachi, Daisuke Kuroda, Shunsuke Kita, et al. (+18)
42 [GO] 2023―Jul―13 Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination X. Tong, R. P. McNamara, M. J. Avendaño, E. F. Serrano, T. García-Salum, C. Pardo-Roa, et al. (+9)
43 [GO] 2023―Jul―11 Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters Liang Zhang, Yao Jiang, Jinhang He, Junyu Chen, Ruoyao Qi, Lunzhi Yuan, et al. (+36)
44 [GO] 2023―Jul―10 Real-time environmental surveillance of SARS-CoV-2 aerosols Joseph V. Puthussery, Dishit P. Ghumra, Kevin R. McBrearty, Brookelyn M. Doherty, Benjamin J. Sumlin, Amirhossein Sarabandi, et al. (+11)
45 [GO] 2023―Jul―10 Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States Aijing Feng, Sarah Bevins, Jeff Chandler, Thomas J. DeLiberto, Ria Ghai, Kristina Lantz, et al. (+8)
46 [GO] 2023―Jul―10 IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation Srikanth Sadhu, Rajdeep Dalal, Jyotsna Dandotiya, Akshay Binayke, Virendra Singh, Manas Ranjan Tripathy, et al. (+5)
47 [GO] 2023―Jul―08 Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men Suad Hannawi, Linda Saifeldin, Alaa Abuquta, Ahmad Alamadi, Sally A. Mahmoud, Aala Hassan, et al. (+9)
48 [GO] 2023―Jul―06 Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking Sophie Graham, Elise Tessier, Julia Stowe, Jamie Lopez Bernal, Edward P. K. Parker, Dorothea Nitsch, et al. (+4)
49 [GO] 2023―Jul―06 Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target Bo Qin, Ziheng Li, Kaiming Tang, Tongyun Wang, Yubin Xie, Sylvain Aumonier, et al. (+3)
50 [GO] 2023―Jul―04 An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo Moriya Tsuji, Manoj S. Nair, Kazuya Masuda, Candace Castagna, Zhenlu Chong, Tamarand L. Darling, et al. (+12)
51 [GO] 2023―Jul―04 In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir Maki Kiso, Yuri Furusawa, Ryuta Uraki, Masaki Imai, Seiya Yamayoshi, Yoshihiro Kawaoka
52 [GO] 2023―Jun―30 High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection Minami Nagai, Miyu Moriyama, Chiharu Ishii, Hirotake Mori, Hikaru Watanabe, Taku Nakahara, et al. (+9)
53 [GO] 2023―Jun―29 Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context Richard J. Sheppard, Oliver J. Watson, Rachel Pieciak, James Lungu, Geoffrey Kwenda, Crispin Moyo, et al. (+17)
54 [GO] 2023―Jun―29 Immunological imprinting of humoral immunity to SARS-CoV-2 in children Alexander C. Dowell, Tara Lancaster, Rachel Bruton, Georgina Ireland, Christopher Bentley, Panagiota Sylla, et al. (+24)
55 [GO] 2023―Jun―29 Increased vaccine sensitivity of an emerging SARS-CoV-2 variant Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, Sally F. Shaw, Bruno Lewin, Harpreet Takhar, et al. (+2)
56 [GO] 2023―Jun―27 Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade Juan Carlos Yam-Puc, Zhaleh Hosseini, Emily C. Horner, Pehuén Pereyra Gerber, Nonantzin Beristain-Covarrubias, Robert Hughes, et al. (+40)
57 [GO] 2023―Jun―27 Genomic screening of 16 UK native bat species through conservationist networks uncovers coronaviruses with zoonotic potential Cedric C. S. Tan, Jahcub Trew, Thomas P. Peacock, Kai Yi Mok, Charlie Hart, Kelvin Lau, et al. (+19)
58 [GO] 2023―Jun―27 In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting Wen Juan Tu, Michelle Melino, Jenny Dunn, Robert D. McCuaig, Helle Bielefeldt-Ohmann, Sofiya Tsimbalyuk, et al. (+20)
59 [GO] 2023―Jun―22 Mutagenesis and structural studies reveal the basis for the specific binding of SARS-CoV-2 SL3 RNA element with human TIA1 protein Dong Zhang, Lulu Qiao, Xiaobo Lei, Xiaojing Dong, Yunguang Tong, Jianwei Wang, et al. (+2)
60 [GO] 2023―Jun―17 Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration Dean Follmann, Meagan P. O’Brien, Jonathan Fintzi, Michael P. Fay, David Montefiori, Allyson Mateja, et al. (+18)
61 [GO] 2023―Jun―16 Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2 Katherine U. Gaynor, Marina Vaysburd, Maximilian A. J. Harman, Anna Albecka, Phillip Jeffrey, Paul Beswick, et al. (+26)
62 [GO] 2023―Jun―15 Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city Joseph A. Lewnard, Chandra Mohan B, Gagandeep Kang, Ramanan Laxminarayan
63 [GO] 2023―Jun―15 Phylodynamic of SARS-CoV-2 during the second wave of COVID-19 in Peru Santiago Justo Arevalo, Carmen Sofia Uribe Calampa, Cinthy Jimenez Silva, Mauro Quiñones Aguilar, Remco Bouckaert, Joao Renato Rebello Pinho
64 [GO] 2023―Jun―15 Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection Yu Guo, Guangshun Zhang, Qi Yang, Xiaowei Xie, Yang Lu, Xuelian Cheng, et al. (+33)
65 [GO] 2023―Jun―13 Author Correction: Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19 Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, Nino Stocker, Anja Heider, Patrick Westermann, et al. (+19)
66 [GO] 2023―Jun―13 Predicting the antigenic evolution of SARS-COV-2 with deep learning Wenkai Han, Ningning Chen, Xinzhou Xu, Adil Sahil, Juexiao Zhou, Zhongxiao Li, et al. (+7)
67 [GO] 2023―Jun―10 Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response Xiaolei Wang, Terrence Tsz-Tai Yuen, Ying Dou, Jingchu Hu, Renhao Li, Zheng Zeng, et al. (+10)
68 [GO] 2023―Jun―09 Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants Charles B. Stauft, Prabhuanand Selvaraj, Felice D’Agnillo, Clement A. Meseda, Shufeng Liu, Cyntia L. Pedro, et al. (+5)
69 [GO] 2023―Jun―09 A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon Debjit Khan, Fulvia Terenzi, GuanQun Liu, Prabar K. Ghosh, Fengchun Ye, Kien Nguyen, et al. (+11)
70 [GO] 2023―Jun―07 Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy Manon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, Aiste Dijokaite-Guraliuc, Raksha Das, Aekkachai Tuekprakhon, et al. (+20)
71 [GO] 2023―Jun―07 The preference signature of the SARS-CoV-2 Nucleocapsid NTD for its 5’-genomic RNA elements Sophie Marianne Korn, Karthikeyan Dhamotharan, Cy M. Jeffries, Andreas Schlundt
72 [GO] 2023―Jun―06 Estimating the impact of COVID-19 vaccine inequities: a modeling study Nicolò Gozzi, Matteo Chinazzi, Natalie E. Dean, Ira M. Longini Jr, M. Elizabeth Halloran, Nicola Perra, Alessandro Vespignani
73 [GO] 2023―Jun―06 GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults Christine D. Palmer, Ciaran D. Scallan, Lauren D. Kraemer Tardif, Melissa A. Kachura, Amy R. Rappaport, Daniel O. Koralek, et al. (+20)
74 [GO] 2023―Jun―05 Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2 Laura Heydemann, Małgorzata Ciurkiewicz, Georg Beythien, Kathrin Becker, Klaus Schughart, Stephanie Stanelle-Bertram, et al. (+9)
75 [GO] 2023―Jun―03 Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants Ana S. Gonzalez-Reiche, Hala Alshammary, Sarah Schaefer, Gopi Patel, Jose Polanco, Juan Manuel Carreño, et al. (+36)
76 [GO] 2023―May―29 Evidence-driven spatiotemporal COVID-19 hospitalization prediction with Ising dynamics Junyi Gao, Joerg Heintz, Christina Mack, Lucas Glass, Adam Cross, Jimeng Sun
77 [GO] 2023―May―25 A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8 Bruno A. Rodriguez-Rodriguez, Grace O. Ciabattoni, Ralf Duerr, Ana M. Valero-Jimenez, Stephen T. Yeung, Keaton M. Crosse, et al. (+13)
78 [GO] 2023―May―24 Long-term exposure to air pollution and severe COVID-19 in Catalonia: a population-based cohort study Otavio Ranzani, Anna Alari, Sergio Olmos, Carles Milà, Alex Rico, Joan Ballester, et al. (+13)
79 [GO] 2023―May―24 Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion Tabea M. Eser, Olga Baranov, Manuel Huth, Mohammed I. M. Ahmed, Flora Deák, Kathrin Held, et al. (+21)
80 [GO] 2023―May―23 Comparative mRNA booster effectiveness against death or hospitalization with COVID-19 pneumonia across at-risk US Veteran populations J. Daniel Kelly, Samuel Leonard, W. John Boscardin, Katherine J. Hoggatt, Emily N. Lum, Charles C. Austin, et al. (+5)
81 [GO] 2023―May―23 An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants Wanbo Tai, Shengyong Feng, Benjie Chai, Shuaiyao Lu, Guangyu Zhao, Dong Chen, et al. (+12)
82 [GO] 2023―May―19 saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern Mai Komori, Takuto Nogimori, Amber L. Morey, Takashi Sekida, Keiko Ishimoto, Matthew R. Hassett, et al. (+12)
83 [GO] 2023―May―17 Enabling accurate and early detection of recently emerged SARS-CoV-2 variants of concern in wastewater Nicolae Sapoval, Yunxi Liu, Esther G. Lou, Loren Hopkins, Katherine B. Ensor, Rebecca Schneider, et al. (+2)
84 [GO] 2023―May―16 Modelling the economic burden of SARS-CoV-2 infection in health care workers in four countries Huihui Wang, Wu Zeng, Kenneth Munge Kabubei, Jennifer J. K. Rasanathan, Jacob Kazungu, Sandile Ginindza, et al. (+9)
85 [GO] 2023―May―16 Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK Jia Wei, Philippa C. Matthews, Nicole Stoesser, John N. Newton, Ian Diamond, Ruth Studley, et al. (+71)
86 [GO] 2023―May―16 Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants Tomokazu Tamura, Jumpei Ito, Keiya Uriu, Jiri Zahradnik, Izumi Kida, Yuki Anraku, et al. (+79)
87 [GO] 2023―May―11 Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant Jumpei Ito, Rigel Suzuki, Keiya Uriu, Yukari Itakura, Jiri Zahradnik, Kanako Terakado Kimura, et al. (+75)
88 [GO] 2023―May―10 Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants Hong Lei, Aqu Alu, Jingyun Yang, Xi He, Cai He, Wenyan Ren, et al. (+13)
89 [GO] 2023―May―05 Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation Yafeng Li, Jessica S. Hook, Qing Ding, Xue Xiao, Stephen S. Chung, Marcel Mettlen, et al. (+3)
90 [GO] 2023―May―03 Detergent modulates the conformational equilibrium of SARS-CoV-2 Spike during cryo-EM structural determination Shawn B. Egri, Xue Wang, Marco A. Díaz-Salinas, Jeremy Luban, Natalya V. Dudkina, James B. Munro, Kuang Shen
91 [GO] 2023―Apr―27 Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong Ruopeng Xie, Kimberly M. Edwards, Dillon C. Adam, Kathy S. M. Leung, Tim K. Tsang, Shreya Gurung, et al. (+15)
92 [GO] 2023―Apr―25 Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils Einav Tayeb-Fligelman, Jeannette T. Bowler, Christen E. Tai, Michael R. Sawaya, Yi Xiao Jiang, Gustavo Garcia, et al. (+22)
93 [GO] 2023―Apr―25 Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin Pawel M. Wydorski, Jerzy Osipiuk, Benjamin T. Lanham, Christine Tesar, Michael Endres, Elizabeth Engle, et al. (+7)
94 [GO] 2023―Apr―24 Sample-to-answer platform for the clinical evaluation of COVID-19 using a deep learning-assisted smartphone-based assay Seungmin Lee, Sunmok Kim, Dae Sung Yoon, Jeong Soo Park, Hyowon Woo, Dongho Lee, et al. (+5)
95 [GO] 2023―Apr―22 Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19 Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, Nino Stocker, Anja Heider, Patrick Westermann, et al. (+19)
96 [GO] 2023―Apr―21 Behavioral changes during the COVID-19 pandemic decreased income diversity of urban encounters Takahiro Yabe, Bernardo García Bulle Bueno, Xiaowen Dong, Alex Pentland, Esteban Moro
97 [GO] 2023―Apr―21 Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6 Taha Y. Taha, Irene P. Chen, Jennifer M. Hayashi, Takako Tabata, Keith Walcott, Gabriella R. Kimmerly, et al. (+13)
98 [GO] 2023―Apr―21 Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice Eakachai Prompetchara, Chutitorn Ketloy, Mohamad-Gabriel Alameh, Kittipan Tharakhet, Papatsara Kaewpang, Nongnaphat Yostrerat, et al. (+16)
99 [GO] 2023―Apr―20 Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase Jan Silhan, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, et al. (+3)
100 [GO] 2023―Apr―19 Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S. Bernardo García-Carreras, Matt D. T. Hitchings, Michael A. Johansson, Matthew Biggerstaff, Rachel B. Slayton, Jessica M. Healy, et al. (+5)
101 [GO] 2023―Apr―19 Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages Mark Chernyshev, Mrunal Sakharkar, Ruth I. Connor, Haley L. Dugan, Daniel J. Sheward, C. G. Rappazzo, et al. (+7)
102 [GO] 2023―Apr―17 A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates Payton A.-B. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S. Arunachalam, Mengyun Hu, et al. (+14)
103 [GO] 2023―Apr―17 Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants Yubin Liu, Ziyi Wang, Xinyu Zhuang, Shengnan Zhang, Zhicheng Chen, Yan Zou, et al. (+18)
104 [GO] 2023―Apr―15 Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19 Meng Yu, Afandi Charles, Alberto Cagigi, Wanda Christ, Björn Österberg, Sara Falck-Jones, et al. (+22)
105 [GO] 2023―Apr―14 Drivers of SARS-CoV-2 testing behaviour: a modelling study using nationwide testing data in England Younjung Kim, Christl A. Donnelly, Pierre Nouvellet
106 [GO] 2023―Apr―14 Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment Rana Abdelnabi, Dirk Jochmans, Kim Donckers, Bettina Trüeb, Nadine Ebert, Birgit Weynand, et al. (+2)
107 [GO] 2023―Apr―12 An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters Shaofeng Deng, Ying Liu, Rachel Chun-Yee Tam, Pin Chen, Anna Jinxia Zhang, Bobo Wing-Yee Mok, et al. (+11)
108 [GO] 2023―Apr―11 Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes Ramandip Grewal, Lena Nguyen, Sarah A. Buchan, Sarah E. Wilson, Sharifa Nasreen, Peter C. Austin, et al. (+7)
109 [GO] 2023―Apr―11 Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas Ighor Arantes, Gonzalo Bello, Valdinete Nascimento, Victor Souza, Arlesson da Silva, Dejanane Silva, et al. (+17)
110 [GO] 2023―Apr―10 Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study Zhuoying Huang, Shuangfei Xu, Jiechen Liu, Linlin Wu, Jing Qiu, Nan Wang, et al. (+10)
111 [GO] 2023―Apr―10 Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient Lena Jaki, Sebastian Weigang, Lisa Kern, Stefanie Kramme, Antoni G. Wrobel, Andrea B. Grawitz, et al. (+18)
112 [GO] 2023―Apr―10 High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike Timothy J. C. Tan, Zongjun Mou, Ruipeng Lei, Wenhao O. Ouyang, Meng Yuan, Ge Song, et al. (+6)
113 [GO] 2023―Apr―07 Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques Laura Solforosi, Lea M. M. Costes, Jeroen T. B. M. Tolboom, Katherine McMahan, Tochi Anioke, David Hope, et al. (+19)
114 [GO] 2023―Apr―06 TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques Amit A. Upadhyay, Elise G. Viox, Timothy N. Hoang, Arun K. Boddapati, Maria Pino, Michelle Y.-H. Lee, et al. (+22)
115 [GO] 2023―Apr―06 Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection Wenjuan Dong, Jing Wang, Lei Tian, Jianying Zhang, Erik W. Settles, Chao Qin, et al. (+18)
116 [GO] 2023―Apr―05 Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes Ramandip Grewal, Lena Nguyen, Sarah A. Buchan, Sarah E. Wilson, Sharifa Nasreen, Peter C. Austin, et al. (+7)
117 [GO] 2023―Apr―05 Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection Daan K. J. Pieren, Sebastián G. Kuguel, Joel Rosado, Alba G. Robles, Joan Rey-Cano, Cristina Mancebo, et al. (+4)
118 [GO] 2023―Apr―04 Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19 Samuel Druzak, Elizabeth Iffrig, Blaine R. Roberts, Tiantian Zhang, Kirby S. Fibben, Yumiko Sakurai, et al. (+28)
119 [GO] 2023―Mar―31 Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals Haogao Gu, Ahmed Abdul Q귮r, Pavithra Krishnan, Daisy Y. M. Ng, Lydia D. J. Chang, Gigi Y. Z. Liu, et al. (+5)
120 [GO] 2023―Mar―30 Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response André Santa Cruz, Ana Mendes-Frias, Marne Azarias-da-Silva, Sónia André, Ana Isabel Oliveira, Olga Pires, et al. (+16)
121 [GO] 2023―Mar―28 Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2 Brian C. Sanders, Suman Pokhrel, Audrey D. Labbe, Irimpan I. Mathews, Connor J. Cooper, Russell B. Davidson, et al. (+27)
122 [GO] 2023―Mar―27 Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England Vahé Nafilyan, Charlotte R. Bermingham, Isobel L. Ward, Jasper Morgan, Francesco Zaccardi, Kamlesh Khunti, et al. (+3)
123 [GO] 2023―Mar―26 Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Youyi Fong, Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo, et al. (+31)
124 [GO] 2023―Mar―26 Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, Sally F. Shaw, Bruno Lewin, Harpreet Takhar, Sara Y. Tartof
125 [GO] 2023―Mar―26 An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition Gabriela Dias Noske, Yun Song, Rafaela Sachetto Fernandes, Rod Chalk, Haitem Elmassoudi, Lizbé Koekemoer, et al. (+5)
126 [GO] 2023―Mar―26 Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain Tomohiro Takano, Takashi Sato, Ryutaro Kotaki, Saya Moriyama, Shuetsu Fukushi, Masahiro Shinoda, et al. (+10)
127 [GO] 2023―Mar―24 Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis Deborah Cromer, Megan Steain, Arnold Reynaldi, Timothy E. Schlub, Shanchita R. Khan, Sarah C. Sasson, et al. (+3)
128 [GO] 2023―Mar―24 Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, Ravi Kant, Petja Salminen, Riku Fagerlund, et al. (+17)
129 [GO] 2023―Mar―23 Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates Ryuta Uraki, Shun Iida, Peter J. Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki-Horimoto, et al. (+24)
130 [GO] 2023―Mar―22 Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, et al. (+10)
131 [GO] 2023―Mar―14 Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein Valeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, Dietmar Hammerschmid, Katie J. Doores, Richard T. Bradshaw, et al. (+7)
132 [GO] 2023―Mar―10 Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G. Anosova, Lu Li, Tim Tibbitts, et al. (+7)
133 [GO] 2023―Mar―09 SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity Jillian R. Jaycox, Carolina Lucas, Inci Yildirim, Yile Dai, Eric Y. Wang, Valter Monteiro, et al. (+12)
134 [GO] 2023―Mar―07 Long-term gastrointestinal outcomes of COVID-19 Evan Xu, Yan Xie, Ziyad Al-Aly
135 [GO] 2023―Mar―02 Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life Ousseny Zerbo, G. Thomas Ray, Bruce Fireman, Evan Layefsky, Kristin Goddard, Edwin Lewis, et al. (+4)
136 [GO] 2023―Mar―02 Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants James Logue, Robert M. Johnson, Nita Patel, Bin Zhou, Sonia Maciejewski, Bryant Foreman, et al. (+17)
137 [GO] 2023―Feb―28 Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase Sebenzile K. Myeni, Peter J. Bredenbeek, Robert C. M. Knaap, Tim J. Dalebout, Shessy Torres Morales, Igor A. Sidorov, et al. (+8)
138 [GO] 2023―Feb―28 CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection B. Vijayalakshmi Ayyar, Khalil Ettayebi, Wilhelm Salmen, Umesh C. Karandikar, Frederick H. Neill, Victoria R. Tenge, et al. (+5)
139 [GO] 2023―Feb―25 Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2 Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai, et al. (+29)
140 [GO] 2023―Feb―24 Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants Haisheng Yu, Banghui Liu, Yudi Zhang, Xijie Gao, Qian Wang, Haitao Xiang, et al. (+33)
141 [GO] 2023―Feb―22 Epidemiological impacts of the NHS COVID-19 app in England and Wales throughout its first year Michelle Kendall, Daphne Tsallis, Chris Wymant, Andrea Di Francia, Yakubu Balogun, Xavier Didelot, et al. (+2)
142 [GO] 2023―Feb―22 National surveillance data analysis of COVID-19 vaccine uptake in England by women of reproductive age Laura A. Magee, Erika Molteni, Vicky Bowyer, Jeffrey N. Bone, Harriet Boulding, Asma Khalil, et al. (+17)
143 [GO] 2023―Feb―20 Magnetically boosted 1D photoactive microswarm for COVID-19 face mask disruption Jeonghyo Kim, Carmen C. Mayorga-Martinez, Martin Pumera
144 [GO] 2023―Feb―20 Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes Taniya Bhardwaj, Kundlik Gadhave, Shivani K. Kapuganti, Prateek Kumar, Zacharias Faidon Brotzakis, Kumar Udit Saumya, et al. (+9)
145 [GO] 2023―Feb―13 Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria Idowu B. Olawoye, Paul E. Oluniyi, Judith U. Oguzie, Jessica N. Uwanibe, Tolulope A. Kayode, Testimony J. Olumade, et al. (+133)
146 [GO] 2023―Feb―13 Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, et al. (+14)
147 [GO] 2023―Feb―11 Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19 Ronja Mothes, Anna Pascual-Reguant, Ralf Koehler, Juliane Liebeskind, Alina Liebheit, Sandy Bauherr, et al. (+26)
148 [GO] 2023―Feb―10 The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England Matt J. Keeling, Samuel Moore, Bridget S. Penman, Edward M. Hill
149 [GO] 2023―Feb―08 Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2 Manon Venet, Margarida Sa Ribeiro, Elodie Décembre, Alicia Bellomo, Garima Joshi, Célia Nuovo, et al. (+11)
150 [GO] 2023―Feb―08 Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients Romain Rouet, Jake Y. Henry, Matt D. Johansen, Meghna Sobti, Harikrishnan Balachandran, David B. Langley, et al. (+21)
151 [GO] 2023―Feb―06 SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection Jernej Pušnik, Werner O. Monzon-Posadas, Jasmin Zorn, Kathrin Peters, Maximilian Baum, Hannah Proksch, et al. (+4)
152 [GO] 2023―Feb―04 Direct Cryo-ET observation of platelet deformation induced by SARS-CoV-2 spike protein Christopher Cyrus Kuhn, Nirakar Basnet, Satish Bodakuntla, Pelayo Alvarez-Brecht, Scott Nichols, Antonio Martinez-Sanchez, et al. (+5)
153 [GO] 2023―Feb―03 A scoping review of the impacts of COVID-19 physical distancing measures on vulnerable population groups Lili Li, Araz Taeihagh, Si Ying Tan
154 [GO] 2023―Feb―03 Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity Wei-Hung Chen, Agnes Hajduczki, Elizabeth J. Martinez, Hongjun Bai, Hanover Matz, Thomas M. Hill, et al. (+39)
155 [GO] 2023―Feb―02 High-depth sequencing characterization of viral dynamics across tissues in fatal COVID-19 reveals compartmentalized infection Erica Normandin, Melissa Rudy, Nikolaos Barkas, Stephen F. Schaffner, Zoe Levine, Robert F. Padera, et al. (+7)
156 [GO] 2023―Jan―19 Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19 Kara W. Chew, Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs, et al. (+19)
157 [GO] 2023―Jan―19 Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape Leander Witte, Viren A. Baharani, Fabian Schmidt, Zijun Wang, Alice Cho, Raphael Raspe, et al. (+9)
158 [GO] 2023―Jan―19 Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Youyi Fong, Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo, et al. (+31)
159 [GO] 2023―Jan―19 Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2 Kuan-Ying A. Huang, Xiaorui Chen, Arpita Mohapatra, Hong Thuy Vy Nguyen, Lisa Schimanski, Tiong Kit Tan, et al. (+13)
160 [GO] 2023―Jan―18 Impact of the Euro 2020 championship on the spread of COVID-19 Jonas Dehning, Sebastian B. Mohr, Sebastian Contreras, Philipp Dönges, Emil N. Iftekhar, Oliver Schulz, et al. (+2)
161 [GO] 2023―Jan―17 Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants Emily E. Bendall, Amy P. Callear, Amy Getz, Kendra Goforth, Drew Edwards, Arnold S. Monto, et al. (+2)
162 [GO] 2023―Jan―16 Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, Anne von Gottberg, Meredith L. McMorrow, Nicole Wolter, et al. (+19)
163 [GO] 2023―Jan―13 Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation Thiago Moreno L. Souza, Vagner D. Pinho, Cristina F. Setim, Carolina Q. Sacramento, Rodrigo Marcon, Natalia Fintelman-Rodrigues, et al. (+29)
164 [GO] 2023―Jan―12 Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa Elsa du Bruyn, Cari Stek, Remi Daroowala, Qonita Said-Hartley, Marvin Hsiao, Georgia Schafer, et al. (+46)
165 [GO] 2023―Jan―12 Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 Hung Fu Tseng, Bradley K. Ackerson, Katia J. Bruxvoort, Lina S. Sy, Julia E. Tubert, Gina S. Lee, et al. (+11)
166 [GO] 2023―Jan―10 Author Correction: Inferring time-varying generation time, serial interval, and incubation period distributions for COVID-19 Dongxuan Chen, Yiu-Chung Lau, Xiao-Ke Xu, Lin Wang, Zhanwei Du, Tim K. Tsang, et al. (+5)
167 [GO] 2023―Jan―10 SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19 Oksana V. Stanevich, Evgeniia I. Alekseeva, Maria Sergeeva, Artem V. Fadeev, Kseniya S. Komissarova, Anna A. Ivanova, et al. (+20)
168 [GO] 2023―Jan―10 SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation Valentino Bezzerri, Valentina Gentili, Martina Api, Alessia Finotti, Chiara Papi, Anna Tamanini, et al. (+16)
169 [GO] 2023―Jan―09 Providing normative information increases intentions to accept a COVID-19 vaccine Alex Moehring, Avinash Collis, Kiran Garimella, M. Amin Rahimian, Sinan Aral, Dean Eckles
170 [GO] 2023―Jan―06 Direct and indirect effects of the COVID-19 pandemic on mortality in Switzerland Julien Riou, Anthony Hauser, Anna Fesser, Christian L. Althaus, Matthias Egger, Garyfallos Konstantinoudis
171 [GO] 2023―Jan―06 A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection Clara Calvert, Jade Carruthers, Cheryl Denny, Jack Donaghy, Lisa E. M. Hopcroft, Leanne Hopkins, et al. (+20)
172 [GO] 2023―Jan―04 B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response Emanuele Andreano, Ida Paciello, Giulio Pierleoni, Giulia Piccini, Valentina Abbiento, Giada Antonelli, et al. (+19)
173 [GO] 2023―Jan―03 Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar Adeel A. Butt, Mylai D. Guerrero, Elenor B. Canlas, Husni Al-Dwairi, Abeir Bakhiet Mohammed Ali Alimam, Abdur Rehman Mohamad, et al. (+8)
174 [GO] 2022―Dec―27 Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, et al. (+19)
175 [GO] 2022―Dec―26 Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19 Allison K. Maher, Katie L. Burnham, Emma M. Jones, Michelle M. H. Tan, Rocel C. Saputil, Laury Baillon, et al. (+12)
176 [GO] 2022―Dec―23 Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2 Xuanming Guo, Jianli Cao, Jian-Piao Cai, Jiayan Wu, Jiangang Huang, Pallavi Asthana, et al. (+16)
177 [GO] 2022―Dec―16 Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19 Hideki Ogura, Jin Gohda, Xiuyuan Lu, Mizuki Yamamoto, Yoshio Takesue, Aoi Son, et al. (+14)
178 [GO] 2022―Dec―15 Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence Jack S. Gisby, Norzawani B. Buang, Artemis Papadaki, Candice L. Clarke, Talat H. Malik, Nicholas Medjeral-Thomas, et al. (+11)
179 [GO] 2022―Dec―14 Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones Noemia S. Lima, Maryam Musayev, Timothy S. Johnston, Danielle A. Wagner, Amy R. Henry, Lingshu Wang, et al. (+50)
180 [GO] 2022―Dec―13 Inferring time-varying generation time, serial interval, and incubation period distributions for COVID-19 Dongxuan Chen, Yiu-Chung Lau, Xiao-Ke Xu, Lin Wang, Zhanwei Du, Tim K. Tsang, et al. (+5)
181 [GO] 2022―Dec―13 Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, et al. (+10)
182 [GO] 2022―Dec―12 Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England Freja Cordelia Møller Kirsebom, Nick Andrews, Ruchira Sachdeva, Julia Stowe, Mary Ramsay, Jamie Lopez Bernal
183 [GO] 2022―Dec―12 Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation Gi Uk Jeong, Hyung-Jun Kwon, Wern Hann Ng, Xiang Liu, Hyun Woo Moon, Gun Young Yoon, et al. (+14)
184 [GO] 2022―Dec―10 The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi Louisa L. Y. Chan, Danielle E. Anderson, Hong Sheng Cheng, Fransiskus Xaverius Ivan, Si Chen, Adrian E. Z. Kang, et al. (+15)
185 [GO] 2022―Dec―09 SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling Scott B. Biering, Francielle Tramontini Gomes de Sousa, Laurentia V. Tjang, Felix Pahmeier, Chi Zhu, Richard Ruan, et al. (+23)
186 [GO] 2022―Dec―07 Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 Nicolas de Prost, Etienne Audureau, Nicholas Heming, Elyanne Gault, Tài Pham, Amal Chaghouri, et al. (+37)
187 [GO] 2022―Dec―06 A call for immediate action to increase COVID-19 vaccination uptake to prepare for the third pandemic winter Cornelia Betsch, Philipp Schmid, Pierre Verger, Stephan Lewandowsky, Anna Soveri, Ralph Hertwig, et al. (+13)
188 [GO] 2022―Nov―30 Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants Karin Magnusson, Doris Tove Kristoffersen, Andrea Dell’Isola, Ali Kiadaliri, Aleksandra Turkiewicz, Jos Runhaar, et al. (+4)
189 [GO] 2022―Nov―28 High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection Eva-Maria Jacobsen, Dorit Fabricius, Magdalena Class, Fernando Topfstedt, Raquel Lorenzetti, Iga Janowska, et al. (+30)
190 [GO] 2022―Nov―27 Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial I’ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain, Aleksandra M. Rzeszutek, Jack Pilgrim, Katie Bullock, et al. (+28)
191 [GO] 2022―Nov―25 Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity Nikaïa Smith, Céline Possémé, Vincent Bondet, Jamie Sugrue, Liam Townsend, Bruno Charbit, et al. (+17)
192 [GO] 2022―Nov―25 Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples Thomas Liechti, Yaser Iftikhar, Massimo Mangino, Margaret Beddall, Charles W. Goss, Jane A. O’Halloran, et al. (+2)
193 [GO] 2022―Nov―25 Comparison of antibody responses to SARS-CoV-2 variants in Australian children Zheng Quan Toh, Nadia Mazarakis, Jill Nguyen, Rachel A. Higgins, Jeremy Anderson, Lien Anh Ha Do, et al. (+7)
194 [GO] 2022―Nov―23 Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain Edward Burn, Elena Roel, Andrea Pistillo, Sergio Fernández-Bertolín, Maria Aragón, Berta Raventós, et al. (+7)
195 [GO] 2022―Nov―23 Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom Edward Burn, Xintong Li, Antonella Delmestri, Nathan Jones, Talita Duarte-Salles, Carlen Reyes, et al. (+6)
196 [GO] 2022―Nov―19 Disparate impacts on online information access during the Covid-19 pandemic Jina Suh, Eric Horvitz, Ryen W. White, Tim Althoff
197 [GO] 2022―Nov―19 Electricity consumption variation versus economic structure during COVID-19 on metropolitan statistical areas in the US Jinning Wang, Fangxing Li, Hantao Cui, Qingxin Shi, Trey Mingee
198 [GO] 2022―Nov―19 Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections Bin Ju, Qing Fan, Miao Wang, Xuejiao Liao, Huimin Guo, Haiyan Wang, et al. (+3)
199 [GO] 2022―Nov―16 Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity Deanna M. Santer, Daniel Li, Yanal Ghosheh, Muhammad Atif Zahoor, Dhanvi Prajapati, Bettina E. Hansen, et al. (+3)
200 [GO] 2022―Nov―16 XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection Pehuén Pereyra Gerber, Maria J. Donde, Nicholas J. Matheson, Alexander I. Taylor
201 [GO] 2022―Nov―16 Global disparities in SARS-CoV-2 genomic surveillance Anderson F. Brito, Elizaveta Semenova, Gytis Dudas, Gabriel W. Hassler, Chaney C. Kalinich, Moritz U. G. Kraemer, et al. (+200)
202 [GO] 2022―Nov―16 Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1 Alief Moulana, Thomas Dupic, Angela M. Phillips, Jeffrey Chang, Serafina Nieves, Anne A. Roffler, et al. (+4)
203 [GO] 2022―Nov―15 Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel Joshua Guedalia, Michal Lipschuetz, Ronit Calderon-Margalit, Sarah M. Cohen, Debra Goldman-Wohl, Tali Kaminer, et al. (+6)
204 [GO] 2022―Nov―15 Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice Anneliese S. Ashhurst, Matt D. Johansen, Joshua W. C. Maxwell, Skye Stockdale, Caroline L. Ashley, Anupriya Aggarwal, et al. (+12)
205 [GO] 2022―Nov―14 Reply to: The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein Mohammed Samer Shaban, Christin Müller, Christin Mayr-Buro, Hendrik Weiser, M. Lienhard Schmitz, John Ziebuhr, Michael Kracht
206 [GO] 2022―Nov―14 The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein Woo-Jin Shin, Dat P. Ha, Keigo Machida, Amy S. Lee
207 [GO] 2022―Nov―14 Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies Lucy B. Cook, Gillian O’Dell, Eleni Vourvou, Renuka Palanicawandar, Sasha Marks, Dragana Milojkovic, et al. (+12)
208 [GO] 2022―Nov―12 Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19 Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Nathalie Charland, Aurélien Lorin, Matthew P. Cheng, et al. (+8)
209 [GO] 2022―Nov―11 Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England Matthew Whitaker, Joshua Elliott, Barbara Bodinier, Wendy Barclay, Helen Ward, Graham Cooke, et al. (+3)
210 [GO] 2022―Nov―11 A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain Ji Wang, Caiguangxi Deng, Ming Liu, Yihao Liu, Liubing Li, Zhangping Huang, et al. (+8)
211 [GO] 2022―Nov―10 Development and validation of self-monitoring auto-updating prognostic models of survival for hospitalized COVID-19 patients Todd J. Levy, Kevin Coppa, Jinxuan Cang, Douglas P. Barnaby, Marc D. Paradis, Stuart L. Cohen, et al. (+6)
212 [GO] 2022―Nov―10 Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome Qin Liu, Qi Su, Fen Zhang, Hein M. Tun, Joyce Wing Yan Mak, Grace Chung-Yan Lui, et al. (+10)
213 [GO] 2022―Nov―10 Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters Shufeng Liu, Charles B. Stauft, Prabhuanand Selvaraj, Prabha Chandrasekaran, Felice D’Agnillo, Chao-Kai Chou, et al. (+7)
214 [GO] 2022―Nov―07 Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection Yonatan Woodbridge, Sharon Amit, Amit Huppert, Naama M. Kopelman
215 [GO] 2022―Nov―04 Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters Sapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe, Winnie Kerstens, Madina Rasulova, Lindsey Bervoets, et al. (+12)
216 [GO] 2022―Nov―03 Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure Matthew R. Stutz, Nicholas P. Dylla, Steven D. Pearson, Paola Lecompte-Osorio, Ravi Nayak, Maryam Khalid, et al. (+21)
217 [GO] 2022―Nov―01 Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia Lucie Bernard-Raichon, Mericien Venzon, Jon Klein, Jordan E. Axelrad, Chenzhen Zhang, Alexis P. Sullivan, et al. (+80)
218 [GO] 2022―Oct―29 Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border Jordan Douglas, David Winter, Andrea McNeill, Sam Carr, Michael Bunce, Nigel French, et al. (+4)
219 [GO] 2022―Oct―27 Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3 Srividhya Swaminathan, Katie E. Lineburg, Archana Panikkar, Jyothy Raju, Lawton D. Murdolo, Christopher Szeto, et al. (+11)
220 [GO] 2022―Oct―26 Ultrafast one-minute electronic detection of SARS-CoV-2 infection by 3CLpro enzymatic activity in untreated saliva samples Ella Borberg, Eran Granot, Fernando Patolsky
221 [GO] 2022―Oct―23 Contact tracing reveals community transmission of COVID-19 in New York City Sen Pei, Sasikiran Kandula, Jaime Cascante Vega, Wan Yang, Steffen Foerster, Corinne Thompson, et al. (+6)
222 [GO] 2022―Oct―23 Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France Antonin Bal, Bruno Simon, Gregory Destras, Richard Chalvignac, Quentin Semanas, Antoine Oblette, et al. (+7)
223 [GO] 2022―Oct―23 Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine Dapeng Li, David R. Martinez, Alexandra Schäfer, Haiyan Chen, Maggie Barr, Laura L. Sutherland, et al. (+38)
224 [GO] 2022―Oct―21 Author Correction: Organ-specific genome diversity of replication-competent SARS-CoV-2 Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts, Amélie Dendooven, Valentino D’Onofrio, Liesbeth Couck, et al. (+17)
225 [GO] 2022―Oct―18 Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial Olli P. O. Nevalainen, Saana Horstia, Sanna Laakkonen, Jarno Rutanen, Jussi M. J. Mustonen, Ilkka E. J. Kalliala, et al. (+53)
226 [GO] 2022―Oct―17 A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection Clara Calvert, Jade Carruthers, Cheryl Denny, Jack Donaghy, Sam Hillman, Lisa E. M. Hopcroft, et al. (+22)
227 [GO] 2022―Oct―17 SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa Adam Abdullahi, David Oladele, Michael Owusu, Steven A. Kemp, James Ayorinde, Abideen Salako, et al. (+37)
228 [GO] 2022―Oct―15 Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways Naoko Iwata-Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo, Takashi Okura, Maino Tahara, Shuetsu Fukushi, et al. (+10)
229 [GO] 2022―Oct―15 Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern Danique M. H. van Rijswijck, Albert Bondt, Max Hoek, Karlijn van der Straten, Tom G. Caniels, Meliawati Poniman, et al. (+6)
230 [GO] 2022―Oct―13 Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions Yang Liu, Xianwen Zhang, Jianying Liu, Hongjie Xia, Jing Zou, Antonio E. Muruato, et al. (+13)
231 [GO] 2022―Oct―13 Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England H. H. Webster, T. Nyberg, M. A. Sinnathamby, N. Abdul Aziz, N. Ferguson, G. Seghezzo, et al. (+12)
232 [GO] 2022―Oct―12 Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 Nicolas de Prost, Etienne Audureau, Nicholas Heming, Elyanne Gault, Tài Pham, Amal Chaghouri, et al. (+37)
233 [GO] 2022―Oct―12 Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort Michael A. Horberg, Eric Watson, Mamta Bhatia, Celeena Jefferson, Julia M. Certa, Seohyun Kim, et al. (+4)
234 [GO] 2022―Oct―12 Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity Claudia Kedor, Helma Freitag, Lil Meyer-Arndt, Kirsten Wittke, Leif G. Hanitsch, Thomas Zoller, et al. (+13)
235 [GO] 2022―Oct―08 Trends in non-COVID-19 hospitalizations prior to and during the COVID-19 pandemic period, United States, 2017-2021 Kelsie Cassell, Casey M. Zipfel, Shweta Bansal, Daniel M. Weinberger
236 [GO] 2022―Oct―07 The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype G. Tuba Barut, Nico Joel Halwe, Adriano Taddeo, Jenna N. Kelly, Jacob Schön, Nadine Ebert, et al. (+38)
237 [GO] 2022―Oct―06 Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil Otavio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, Giovanny V. A. de França, Cássia de Fátima R. Fernandes, Margaret L. Lind, et al. (+11)
238 [GO] 2022―Oct―06 DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2 Elizabeth M. Parzych, Jianqiu Du, Ali R. Ali, Katherine Schultheis, Drew Frase, Trevor R. F. Smith, et al. (+26)
239 [GO] 2022―Oct―05 Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants Claudia Del Vecchio, Bethan Cracknell Daniels, Giuseppina Brancaccio, Alessandra Rosalba Brazzale, Enrico Lavezzo, Constanze Ciavarella, et al. (+9)
240 [GO] 2022―Oct―04 Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa Nicole Wolter, Waasila Jassat, Sibongile Walaza, Richard Welch, Harry Moultrie, Michelle J. Groome, et al. (+23)
241 [GO] 2022―Oct―03 IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern Matthew R. Chang, Luke Tomasovic, Natalia A. Kuzmina, Adam J. Ronk, Patrick O. Byrne, Rebecca Johnson, et al. (+19)
242 [GO] 2022―Oct―02 Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study Madhumita Shrotri, Ellen Fragaszy, Vincent Nguyen, Annalan M. D. Navaratnam, Cyril Geismar, Sarah Beale, et al. (+10)
243 [GO] 2022―Sep―30 Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study Julia Stowe, Nick Andrews, Freja Kirsebom, Mary Ramsay, Jamie Lopez Bernal
244 [GO] 2022―Sep―30 Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark Frederik Plesner Lyngse, Carsten Thure Kirkeby, Matthew Denwood, Lasse Engbo Christiansen, Kåre Mølbak, Camilla Holten Møller, et al. (+13)
245 [GO] 2022―Sep―29 SARS-CoV-2 infects adipose tissue in a fat depot- and viral lineage-dependent manner Tatiana Dandolini Saccon, Felippe Mousovich-Neto, Raissa Guimarães Ludwig, Victor Corasolla Carregari, Ana Beatriz dos Anjos Souza, Amanda Stephane Cruz dos Passos, et al. (+43)
246 [GO] 2022―Sep―29 Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants Neda Jalali, Hilde K. Brustad, Arnoldo Frigessi, Emily A. MacDonald, Hinta Meijerink, Siri L. Feruglio, et al. (+4)
247 [GO] 2022―Sep―28 Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland Gudmundur L. Norddahl, Pall Melsted, Kristbjorg Gunnarsdottir, Gisli H. Halldorsson, Thorunn A. Olafsdottir, Arnaldur Gylfason, et al. (+7)
248 [GO] 2022―Sep―26 Circulating multimeric immune complexes contribute to immunopathology in COVID-19 Jakob Ankerhold, Sebastian Giese, Philipp Kolb, Andrea Maul-Pavicic, Reinhard E. Voll, Nathalie Göppert, et al. (+14)
249 [GO] 2022―Sep―23 Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data Rhys P. D. Inward, Kris V. Parag, Nuno R. Faria
250 [GO] 2022―Sep―23 Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection Elham Khatamzas, Markus H. Antwerpen, Alexandra Rehn, Alexander Graf, Johannes Christian Hellmuth, Alexandra Hollaus, et al. (+24)
251 [GO] 2022―Sep―23 Household transmission of the SARS-CoV-2 Omicron variant in Denmark Frederik Plesner Lyngse, Laust Hvas Mortensen, Matthew J. Denwood, Lasse Engbo Christiansen, Camilla Holten Møller, Robert Leo Skov, et al. (+13)
252 [GO] 2022―Sep―22 Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth Zhiqiang Ku, Xuping Xie, Jianqing Lin, Peng Gao, Bin Wu, Abbas El Sahili, et al. (+19)
253 [GO] 2022―Sep―22 Tracking changes in SARS-CoV-2 transmission with a novel outpatient sentinel surveillance system in Chicago, USA Reese Richardson, Emile Jorgensen, Philip Arevalo, Tobias M. Holden, Katelyn M. Gostic, Massimo Pacilli, et al. (+4)
254 [GO] 2022―Sep―21 Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity Martin J. Scurr, George Lippiatt, Lorenzo Capitani, Kirsten Bentley, Sarah N. Lauder, Kathryn Smart, et al. (+6)
255 [GO] 2022―Sep―21 The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition Chihiro Motozono, Mako Toyoda, Toong Seng Tan, Hiroshi Hamana, Yoshihiko Goto, Yoshiki Aritsu, et al. (+8)
256 [GO] 2022―Sep―20 Publishing a pandemic
257 [GO] 2022―Sep―17 A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19 Chih-Jung Chen, Lan-Yan Yang, Wei-Yang Chang, Yhu-Chering Huang, Cheng-Hsun Chiu, Shin-Ru Shih, et al. (+2)
258 [GO] 2022―Sep―12 Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial Daniel Mrak, Daniela Sieghart, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, et al. (+36)
259 [GO] 2022―Sep―12 Reply to: Machine-learning prediction of hosts of novel coronaviruses requires caution as it may affect wildlife conservation Marcus S. C. Blagrove, Matthew Baylis, Maya Wardeh
260 [GO] 2022―Sep―12 Machine-learning prediction of hosts of novel coronaviruses requires caution as it may affect wildlife conservation Sophie Lund Rasmussen, Cino Pertoldi, David W. Macdonald
261 [GO] 2022―Sep―08 The impact of repeated rapid test strategies on the effectiveness of at-home antiviral treatments for SARS-CoV-2 Tigist F. Menkir, Christl A. Donnelly
262 [GO] 2022―Sep―08 Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro Mikhail A. Hameedi, Erica T. Prates, Michael R. Garvin, Irimpan I. Mathews, B. Kirtley Amos, Omar Demerdash, et al. (+12)
263 [GO] 2022―Sep―08 Publisher Correction: Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections Qinghong Fan, Jingrong Shi, Yanhong Yang, Guofang Tang, Mengling Jiang, Jiaojiao Li, et al. (+24)
264 [GO] 2022―Sep―06 Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine Nozomi Kuse, Yu Zhang, Takayuki Chikata, Hung The Nguyen, Shinichi Oka, Hiroyuki Gatanaga, Masafumi Takiguchi
265 [GO] 2022―Sep―06 Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus Ana A. Weil, Kyle G. Luiten, Amanda M. Casto, Julia C. Bennett, Jessica O’Hanlon, Peter D. Han, et al. (+23)
266 [GO] 2022―Sep―06 Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes Shanlin Ke, Scott T. Weiss, Yang-Yu Liu
267 [GO] 2022―Sep―03 Interrupted-time-series analysis of the immediate impact of COVID-19 mitigation measures on preterm birth in China Yanxia Xie, Yi Mu, Peiran Chen, Zheng Liu, Yanping Wang, Qi Li, et al. (+3)
268 [GO] 2022―Sep―03 Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy Shouheng Jin, Xing He, Ling Ma, Zhen Zhuang, Yiliang Wang, Meng Lin, et al. (+13)
269 [GO] 2022―Sep―03 X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation Jaeyong Lee, Calem Kenward, Liam J. Worrall, Marija Vuckovic, Francesco Gentile, Anh-Tien Ton, et al. (+4)
270 [GO] 2022―Sep―01 SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals Kaori Sano, Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason, et al. (+23)
271 [GO] 2022―Aug―30 Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategy Victoria N. Parikh, Alexander G. Ioannidis, David Jimenez-Morales, John E. Gorzynski, Hannah N. De Jong, Xiran Liu, et al. (+64)
272 [GO] 2022―Aug―30 Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates Romain Marlin, Delphine Desjardins, Vanessa Contreras, Guillaume Lingas, Caroline Solas, Pierre Roques, et al. (+21)
273 [GO] 2022―Aug―30 A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity C. Kedor, H. Freitag, L. Meyer-Arndt, K. Wittke, L. G. Hanitsch, T. Zoller, et al. (+13)
274 [GO] 2022―Aug―26 Call for a unified approach to Monkeypox infection in pregnancy: Lessons from the COVID-19 pandemic Asma Khalil, Athina Samara, Pat O’Brien, Shamez Ladhani
275 [GO] 2022―Aug―24 Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape Zhennan Zhao, Jingya Zhou, Mingxiong Tian, Min Huang, Sheng Liu, Yufeng Xie, et al. (+16)
276 [GO] 2022―Aug―22 Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19 Kara W. Chew, Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs, et al. (+19)
277 [GO] 2022―Aug―22 The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force Qingbo S. Wang, Ryuya Edahiro, Ho Namkoong, Takanori Hasegawa, Yuya Shirai, Kyuto Sonehara, et al. (+437)
278 [GO] 2022―Aug―22 Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV Alessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, Giulia Matusali, Veronica Bordoni, Simone Lanini, et al. (+54)
279 [GO] 2022―Aug―22 Comparison of the 2021 COVID-19 roadmap projections against public health data in England Matt J. Keeling, Louise Dyson, Michael J. Tildesley, Edward M. Hill, Samuel Moore
280 [GO] 2022―Aug―20 Designing isolation guidelines for COVID-19 patients with rapid antigen tests Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Woo Joohyeon, Shoya Iwanami, Yasuhisa Fujita, et al. (+6)
281 [GO] 2022―Aug―19 Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era Rosanna C. Barnard, Nicholas G. Davies, James D. Munday, Rachel Lowe, Gwenan M. Knight, Quentin J. Leclerc, et al. (+54)
282 [GO] 2022―Aug―18 BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19 Georg M. N. Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi V. Stankov, Ivan Odak, et al. (+22)
283 [GO] 2022―Aug―18 SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort Robert W. Aldridge, Alexei Yavlinsky, Vincent Nguyen, Max T. Eyre, Madhumita Shrotri, Annalan M. D. Navaratnam, et al. (+11)
284 [GO] 2022―Aug―18 SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization Dhiraj Mannar, James W. Saville, Zehua Sun, Xing Zhu, Michelle M. Marti, Shanti S. Srivastava, et al. (+13)
285 [GO] 2022―Aug―17 Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study Peter D. Kirwan, Andre Charlett, Paul Birrell, Suzanne Elgohari, Russell Hope, Sema Mandal, et al. (+2)
286 [GO] 2022―Aug―17 Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein Julia T. Castro, Patrick Azevedo, Marcílio J. Fumagalli, Natalia S. Hojo-Souza, Natalia Salazar, Gregório G. Almeida, et al. (+27)
287 [GO] 2022―Aug―15 ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19 Maik Pietzner, Robert Lorenz Chua, Eleanor Wheeler, Katharina Jechow, Julian D. S. Willett, Helena Radbruch, et al. (+13)
288 [GO] 2022―Aug―15 Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland Colin R. Simpson, Steven Kerr, Srinivasa Vittal Katikireddi, Colin McCowan, Lewis D. Ritchie, Jiafeng Pan, et al. (+9)
289 [GO] 2022―Aug―15 Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions Edyth Parker, Catelyn Anderson, Mark Zeller, Ahmad Tibi, Jennifer L. Havens, Geneviève Laroche, et al. (+24)
290 [GO] 2022―Aug―15 Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, et al. (+23)
291 [GO] 2022―Aug―13 Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period Pilar T. V. Florentino, Flávia J. O. Alves, Thiago Cerqueira-Silva, Vinicius de Araújo Oliveira, Juracy B. S. Júnior, Adelson G. Jantsch, et al. (+8)
292 [GO] 2022―Aug―13 Empirical evidence on the efficiency of backward contact tracing in COVID-19 Joren Raymenants, Caspar Geenen, Jonathan Thibaut, Klaas Nelissen, Sarah Gorissen, Emmanuel Andre
293 [GO] 2022―Aug―12 Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C Juanjie Tang, Tanya Novak, Julian Hecker, Gabrielle Grubbs, Fatema Tuz Zahra, Lorenza Bellusci, et al. (+33)
294 [GO] 2022―Aug―12 Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, Caroline van den Ende, Noortje van Maarseveen, Lubna Ali, et al. (+7)
295 [GO] 2022―Aug―11 Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens Verena Klemis, Tina Schmidt, David Schub, Janine Mihm, Stefanie Marx, Amina Abu-Omar, et al. (+10)
296 [GO] 2022―Aug―11 SARS-CoV-2 and other respiratory pathogens are detected in continuous air samples from congregate settings Mitchell D. Ramuta, Christina M. Newman, Savannah F. Brakefield, Miranda R. Stauss, Roger W. Wiseman, Amanda Kita-Yarbro, et al. (+22)
297 [GO] 2022―Aug―10 Science in the time of COVID-19: Reflections on the UK Events Research Programme Theresa M. Marteau, Michael J. Parker, W. John Edmunds
298 [GO] 2022―Aug―09 A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia Cecilia A. Sánchez, Hongying Li, Kendra L. Phelps, Carlos Zambrana-Torrelio, Lin-Fa Wang, Peng Zhou, et al. (+3)
299 [GO] 2022―Aug―09 A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples Yanan Tang, Turun Song, Lu Gao, Saifu Yin, Ming Ma, Yun Tan, et al. (+5)
300 [GO] 2022―Aug―08 COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation Matthias Reinscheid, Hendrik Luxenburger, Vivien Karl, Anne Graeser, Sebastian Giese, Kevin Ciminski, et al. (+19)
301 [GO] 2022―Aug―08 Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination Lorenza Bellusci, Gabrielle Grubbs, Fatema Tuz Zahra, David Forgacs, Hana Golding, Ted M. Ross, Surender Khurana
302 [GO] 2022―Aug―08 ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants Neeltje van Doremalen, Jonathan E. Schulz, Danielle R. Adney, Taylor A. Saturday, Robert J. Fischer, Claude Kwe Yinda, et al. (+11)
303 [GO] 2022―Aug―06 Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection Guillermo Barturen, Elena Carnero-Montoro, Manuel Martínez-Bueno, Silvia Rojo-Rello, Beatriz Sobrino, Óscar Porras-Perales, et al. (+3)
304 [GO] 2022―Aug―05 Structure of SARS-CoV-2 membrane protein essential for virus assembly Zhikuan Zhang, Norimichi Nomura, Yukiko Muramoto, Toru Ekimoto, Tomoko Uemura, Kehong Liu, et al. (+8)
305 [GO] 2022―Aug―04 A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike Mathieu Claireaux, Tom G. Caniels, Marlon de Gast, Julianna Han, Denise Guerra, Gius Kerster, et al. (+27)
306 [GO] 2022―Aug―03 An intranasal ASO therapeutic targeting SARS-CoV-2 Chi Zhu, Justin Y. Lee, Jia Z. Woo, Lei Xu, Xammy Nguyenla, Livia H. Yamashiro, et al. (+17)
307 [GO] 2022―Aug―03 Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England Paul Elliott, Oliver Eales, Barbara Bodinier, David Tang, Haowei Wang, Jakob Jonnerby, et al. (+16)
308 [GO] 2022―Aug―02 Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes Samah Hayek, Yatir Ben-shlomo, Noa Dagan, Ben Y. Reis, Noam Barda, Eldad Kepten, et al. (+6)
309 [GO] 2022―Aug―01 Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections Nina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Lene Surland Knudsen, et al. (+20)
310 [GO] 2022―Jul―29 SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model Carolin M. Lieber, Robert M. Cox, Julien Sourimant, Josef D. Wolf, Kate Juergens, Quynh Phung, et al. (+9)
311 [GO] 2022―Jul―29 A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions Yang Liu, Xianwen Zhang, Jianying Liu, Hongjie Xia, Jing Zou, Antonio E. Muruato, et al. (+13)
312 [GO] 2022―Jul―28 Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England Oliver Eales, Leonardo de Oliveira Martins, Andrew J. Page, Haowei Wang, Barbara Bodinier, David Tang, et al. (+13)
313 [GO] 2022―Jul―27 Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines Li Wang, Markus H. Kainulainen, Nannan Jiang, Han Di, Gaston Bonenfant, Lisa Mills, et al. (+78)
314 [GO] 2022―Jul―27 Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Martje Fentener van Vlissingen, et al. (+26)
315 [GO] 2022―Jul―25 An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence Mario Morvan, Anna Lo Jacomo, Celia Souque, Matthew J. Wade, Till Hoffmann, Koen Pouwels, et al. (+10)
316 [GO] 2022―Jul―25 Length-dependent motions of SARS-CoV-2 frameshifting RNA pseudoknot and alternative conformations suggest avenues for frameshifting suppression Shuting Yan, Qiyao Zhu, Swati Jain, Tamar Schlick
317 [GO] 2022―Jul―21 A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark Anna Irene Vedel Sørensen, Lampros Spiliopoulos, Peter Bager, Nete Munk Nielsen, Jørgen Vinsløv Hansen, Anders Koch, et al. (+3)
318 [GO] 2022―Jul―21 Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR Kenneth Danh, Donna Grace Karp, Malvika Singhal, Akshaya Tankasala, David Gebhart, Felipe de Jesus Cortez, et al. (+18)
319 [GO] 2022―Jul―20 A Bayesian approach to infer recombination patterns in coronaviruses Nicola F. Müller, Kathryn E. Kistler, Trevor Bedford
320 [GO] 2022―Jul―19 Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome Anahita Fathi, Christine Dahlke, Verena Krähling, Alexandra Kupke, Nisreen M. A. Okba, Matthijs P. Raadsen, et al. (+21)
321 [GO] 2022―Jul―18 Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults Hassen Kared, Asia-Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, et al. (+11)
322 [GO] 2022―Jul―15 Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) study Husam M. Salah, Marat Fudim, Shawn T. O’Neil, Amin Manna, Christopher G. Chute, Melissa C. Caughey
323 [GO] 2022―Jul―12 Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand Lauren Jelley, Jordan Douglas, Xiaoyun Ren, David Winter, Andrea McNeill, Sue Huang, et al. (+5)
324 [GO] 2022―Jul―09 Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections Qinghong Fan, Jingrong Shi, Yanhong Yang, Guofang Tang, Mengling Jiang, Jiaojiao Li, et al. (+24)
325 [GO] 2022―Jul―08 Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults Lior Rennert, Zichen Ma, Christopher S. McMahan, Delphine Dean
326 [GO] 2022―Jul―08 Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children Eran Mick, Alexandra Tsitsiklis, Natasha Spottiswoode, Saharai Caldera, Paula Hayakawa Serpa, Angela M. Detweiler, et al. (+16)
327 [GO] 2022―Jul―08 A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection Iris N. Pardieck, Tetje C. van der Sluis, Esmé T. I. van der Gracht, Dominique M. B. Veerkamp, Felix M. Behr, Suzanne van Duikeren, et al. (+20)
328 [GO] 2022―Jul―07 Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera Raveen Rathnasinghe, Sonia Jangra, Chengjin Ye, Anastasija Cupic, Gagandeep Singh, Carles Martínez-Romero, et al. (+41)
329 [GO] 2022―Jul―05 Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic Thandavarayan Ramamurthy, Agila Kumari Pragasam, Alyce Taylor-Brown, Robert C. Will, Karthick Vasudevan, Bhabatosh Das, et al. (+12)
330 [GO] 2022―Jul―04 Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs Meriem Bekliz, Kenneth Adea, Pauline Vetter, Christiane S. Eberhardt, Krisztina Hosszu-Fellous, Diem-Lan Vu, et al. (+10)
331 [GO] 2022―Jul―02 Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains James Brett Case, Samantha Mackin, John M. Errico, Zhenlu Chong, Emily A. Madden, Bradley Whitener, et al. (+19)
332 [GO] 2022―Jul―01 Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021 Jeffrey V. Lazarus, Katarzyna Wyka, Trenton M. White, Camila A. Picchio, Kenneth Rabin, Scott C. Ratzan, et al. (+3)
333 [GO] 2022―Jun―30 Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern Frederik Plesner Lyngse, Kåre Mølbak, Matt Denwood, Lasse Engbo Christiansen, Camilla Holten Møller, Morten Rasmussen, et al. (+7)
334 [GO] 2022―Jun―29 Author Correction: The SARS-CoV-2 spike protein is vulnerable to moderate electric fields Claudia R. Arbeitman, Pablo Rojas, Pedro Ojeda-May, Martin E. Garcia
335 [GO] 2022―Jun―29 SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection Jia Wei, Philippa C. Matthews, Nicole Stoesser, Ian Diamond, Ruth Studley, Emma Rourke, et al. (+72)
336 [GO] 2022―Jun―28 Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms Caroline G. Atyeo, Lydia L. Shook, Sara Brigida, Rose M. De Guzman, Stepan Demidkin, Cordelia Muir, et al. (+18)
337 [GO] 2022―Jun―28 Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, et al. (+23)
338 [GO] 2022―Jun―25 COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods Florian B. Mayr, Victor B. Talisa, Alexander D. Castro, Obaid S. Shaikh, Saad B. Omer, Adeel A. Butt
339 [GO] 2022―Jun―25 Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines Stéphane Le Vu, Marion Bertrand, Marie-Joelle Jabagi, Jérémie Botton, Jérôme Drouin, Bérangère Baricault, et al. (+3)
340 [GO] 2022―Jun―25 Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in children Felix Dewald, Isabelle Suárez, Ronja Johnen, Jan Grossbach, Roberto Moran-Tovar, Gertrud Steger, et al. (+51)
341 [GO] 2022―Jun―25 Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City Joel O. Wertheim, Jade C. Wang, Mindy Leelawong, Darren P. Martin, Jennifer L. Havens, Moinuddin A. Chowdhury, et al. (+18)
342 [GO] 2022―Jun―24 Author Correction: Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection Simon J. L. Petitjean, Wenzhang Chen, Melanie Koehler, Ravikumar Jimmidi, Jinsung Yang, Danahe Mohammed, et al. (+5)
343 [GO] 2022―Jun―23 A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge Biao Zhou, Runhong Zhou, Bingjie Tang, Jasper Fuk-Woo Chan, Mengxiao Luo, Qiaoli Peng, et al. (+18)
344 [GO] 2022―Jun―23 Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine Chaitanya Kurhade, Jing Zou, Hongjie Xia, Hui Cai, Qi Yang, Mark Cutler, et al. (+6)
345 [GO] 2022―Jun―21 Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses Zepeng Xu, Xinrui Kang, Pu Han, Pei Du, Linjie Li, Anqi Zheng, et al. (+6)
346 [GO] 2022―Jun―21 Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance Ala M. Shaqra, Sarah N. Zvornicanin, Qiu Yu J. Huang, Gordon J. Lockbaum, Mark Knapp, Laura Tandeske, et al. (+7)
347 [GO] 2022―Jun―20 SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters Federico Armando, Georg Beythien, Franziska K. Kaiser, Lisa Allnoch, Laura Heydemann, Malgorzata Rosiak, et al. (+9)
348 [GO] 2022―Jun―17 A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants Scotland E. Farley, Jennifer E. Kyle, Hans C. Leier, Lisa M. Bramer, Jules B. Weinstein, Timothy A. Bates, et al. (+4)
349 [GO] 2022―Jun―16 Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine Kevin J. Kramer, Erin M. Wilfong, Kelsey Voss, Sierra M. Barone, Andrea R. Shiakolas, Nagarajan Raju, et al. (+14)
350 [GO] 2022―Jun―14 Opportunities to tackle structural racism and ethnicity-based discrimination in recovering and rebuilding from the COVID-19 pandemic Natalia Linos, Mary T. Bassett, Alejandra Salemi, Margareta Matache, Konstantinos Tararas, Rodney Kort, et al. (+9)
351 [GO] 2022―Jun―13 Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19 Mirren Charnley, Saba Islam, Guneet K. Bindra, Jeremy Engwirda, Julian Ratcliffe, Jiangtao Zhou, et al. (+5)
352 [GO] 2022―Jun―13 Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees Emanuele Andreano, Ida Paciello, Silvia Marchese, Lorena Donnici, Giulio Pierleoni, Giulia Piccini, et al. (+13)
353 [GO] 2022―Jun―10 Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination Aloysious Ssemaganda, Huong Mai Nguyen, Faisal Nuhu, Naima Jahan, Catherine M. Card, Sandra Kiazyk, et al. (+11)
354 [GO] 2022―Jun―09 Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates Nawal Al Kaabi, Abderrahim Oulhaj, Subhashini Ganesan, Farida Ismail Al Hosani, Omer Najim, Halah Ibrahim, et al. (+24)
355 [GO] 2022―Jun―09 Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine Tal Patalon, Yaki Saciuk, Asaf Peretz, Galit Perez, Yoav Lurie, Yasmin Maor, Sivan Gazit
356 [GO] 2022―Jun―09 Mitigation of SARS-CoV-2 transmission at a large public university Diana Rose E. Ranoa, Robin L. Holland, Fadi G. Alnaji, Kelsie J. Green, Leyi Wang, Richard L. Fredrickson, et al. (+143)
357 [GO] 2022―Jun―08 Rapid, adaptable and sensitive Cas13-based COVID-19 diagnostics using ADESSO Beatrice Casati, Joseph Peter Verdi, Alexander Hempelmann, Maximilian Kittel, Andrea Gutierrez Klaebisch, Bianca Meister, et al. (+12)
358 [GO] 2022―Jun―07 Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection Amy R. Rappaport, Sue-Jean Hong, Ciaran D. Scallan, Leonid Gitlin, Arvin Akoopie, Gregory R. Boucher, et al. (+9)
359 [GO] 2022―Jun―06 Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 Anna-Lisa Sorg, Leon Bergfeld, Marietta Jank, Victor Corman, Ilia Semmler, Anna Goertz, et al. (+25)
360 [GO] 2022―Jun―06 Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 Zhenhao Fang, Lei Peng, Renata Filler, Kazushi Suzuki, Andrew McNamara, Qianqian Lin, et al. (+13)
361 [GO] 2022―Jun―03 Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories Yong Ge, Wen-Bin Zhang, Xilin Wu, Corrine W. Ruktanonchai, Haiyan Liu, Jianghao Wang, et al. (+10)
362 [GO] 2022―Jun―02 Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Peter Coyle, Patrick Tang, Hadi M. Yassine, et al. (+18)
363 [GO] 2022―May―31 A framework for reconstructing SARS-CoV-2 transmission dynamics using excess mortality data Mahan Ghafari, Oliver J. Watson, Ariel Karlinsky, Luca Ferretti, Aris Katzourakis
364 [GO] 2022―May―31 Author Correction: SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters Wei Qiao, Hui En Lau, Huizhi Xie, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Hin Chu, et al. (+11)
365 [GO] 2022―May―27 Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C Juanjie Tang, Tanya Novak, Julian Hecker, Gabrielle Grubbs, Fatema Tuz Zahra, Lorenza Bellusci, et al. (+33)
366 [GO] 2022―May―27 Transmission of SARS-CoV-2 from humans to animals and potential host adaptation Cedric C. S. Tan, Su Datt Lam, Damien Richard, Christopher J. Owen, Dorothea Berchtold, Christine Orengo, et al. (+5)
367 [GO] 2022―May―26 Combining rapid antigen testing and syndromic surveillance improves community-based COVID-19 detection in a low-income country Fergus J. Chadwick, Jessica Clark, Shayan Chowdhury, Tasnuva Chowdhury, David J. Pascall, Yacob Haddou, et al. (+18)
368 [GO] 2022―May―26 Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2 Jing Zou, Chaitanya Kurhade, Hongjie Xia, Mingru Liu, Xuping Xie, Ping Ren, Pei-Yong Shi
369 [GO] 2022―May―26 SARS-CoV-2 accessory proteins reveal distinct serological signatures in children Asmaa Hachim, Haogao Gu, Otared Kavian, Masashi Mori, Mike Y. W. Kwan, Wai Hung Chan, et al. (+14)
370 [GO] 2022―May―26 SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5 Uddhav Timilsina, Supawadee Umthong, Emily B. Ivey, Brandon Waxman, Spyridon Stavrou
371 [GO] 2022―May―25 Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes Chunyan Wang, Emma L. Hesketh, Tatiana M. Shamorkina, Wentao Li, Peter J. Franken, Dubravka Drabek, et al. (+9)
372 [GO] 2022―May―24 Off-season RSV epidemics in Australia after easing of COVID-19 restrictions John-Sebastian Eden, Chisha Sikazwe, Ruopeng Xie, Yi-Mo Deng, Sheena G. Sullivan, Alice Michie, et al. (+27)
373 [GO] 2022―May―24 Competent immune responses to SARS-CoV-2 variants in older adults following two doses of mRNA vaccination Mladen Jergović, Jennifer L. Uhrlaub, Makiko Watanabe, Christine M. Bradshaw, Lisa M. White, Bonnie J. LaFleur, et al. (+5)
374 [GO] 2022―May―19 Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro Leiping Zeng, Yanxia Liu, Xammy Huu Nguyenla, Timothy R. Abbott, Mengting Han, Yanyu Zhu, et al. (+22)
375 [GO] 2022―May―19 SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity Wuji Zhang, Brendon Y. Chua, Kevin J. Selva, Lukasz Kedzierski, Thomas M. Ashhurst, Ebene R. Haycroft, et al. (+45)
376 [GO] 2022―May―19 SARS-CoV-2 transmission and impacts of unvaccinated-only screening in populations of mixed vaccination status Kate M. Bubar, Casey E. Middleton, Kristen K. Bjorkman, Roy Parker, Daniel B. Larremore
377 [GO] 2022―May―18 Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance Rebecca J. Rockett, Jenny Draper, Mailie Gall, Eby M. Sim, Alicia Arnott, Jessica E. Agius, et al. (+19)
378 [GO] 2022―May―13 A broader perspective on the economics of malaria prevention and the potential impact of SARS-CoV-2 Elisa Sicuri, Francesco Ramponi, Iris Lopes-Rafegas, Francisco Saúte
379 [GO] 2022―May―13 Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant Fanglei Zuo, Hassan Abolhassani, Likun Du, Antonio Piralla, Federico Bertoglio, Leire de Campos-Mata, et al. (+22)
380 [GO] 2022―May―13 Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants Yin-Feng Kang, Cong Sun, Jing Sun, Chu Xie, Zhen Zhuang, Hui-Qin Xu, et al. (+6)
381 [GO] 2022―May―11 Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19 Ting Lu, Rui Ma, Wenjuan Dong, Kun-Yu Teng, Daniel S. Kollath, Zhiyao Li, et al. (+12)
382 [GO] 2022―May―11 Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany, Casper Rokx, Corine Geurtsvankessel, Grigorios Papageourgiou, et al. (+192)
383 [GO] 2022―May―10 Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy Smriti Prasad, Erkan Kalafat, Helena Blakeway, Rosemary Townsend, Pat O’Brien, Edward Morris, et al. (+8)
384 [GO] 2022―May―10 Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection Simon J. L. Petitjean, Wenzhang Chen, Melanie Koehler, Ravikumar Jimmidi, Jinsung Yang, Danahe Mohammed, et al. (+5)
385 [GO] 2022―May―10 Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host Sissy Therese Sonnleitner, Martina Prelog, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B. C. Kopecky, et al. (+7)
386 [GO] 2022―May―10 Archival influenza virus genomes from Europe reveal genomic variability during the 1918 pandemic Livia V. Patrono, Bram Vrancken, Matthias Budt, Ariane Düx, Sebastian Lequime, Sengül Boral, et al. (+20)
387 [GO] 2022―May―09 SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters Wei Qiao, Hui En Lau, Huizhi Xie, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Hin Chu, et al. (+11)
388 [GO] 2022―May―06 Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021 Collins M. Morang’a, Joyce M. Ngoi, Jones Gyamfi, Dominic S. Y. Amuzu, Benjamin D. Nuertey, Philip M. Soglo, et al. (+50)
389 [GO] 2022―May―05 Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants Milja Belik, Pinja Jalkanen, Rickard Lundberg, Arttu Reinholm, Larissa Laine, Elina Väisänen, et al. (+19)
390 [GO] 2022―May―04 Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2 Isobel Routledge, Saki Takahashi, Adrienne Epstein, Jill Hakim, Owen Janson, Keirstinne Turcios, et al. (+9)
391 [GO] 2022―May―04 Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen Alice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher, Nathalie Arhel, Artem Baidaliuk, Sandie Munier, et al. (+19)
392 [GO] 2022―May―02 Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C Conor McCafferty, Tengyi Cai, Delphine Borgel, Dominique Lasne, Sylvain Renolleau, Meryl Vedrenne-Cloquet, et al. (+12)
393 [GO] 2022―Apr―29 Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England T. Beaney, A. L. Neves, A. Alboksmaty, H. Ashrafian, K. Flott, A. Fowler, et al. (+5)
394 [GO] 2022―Apr―28 An energizing role for motivation in information-seeking during the early phase of the COVID-19 pandemic Yaniv Abir, Caroline B. Marvin, Camilla van Geen, Maya Leshkowitz, Ran R. Hassin, Daphna Shohamy
395 [GO] 2022―Apr―28 Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes Raffaele Marfella, Celestino Sardu, Nunzia D’Onofrio, Francesco Prattichizzo, Lucia Scisciola, Vincenzo Messina, et al. (+6)
396 [GO] 2022―Apr―27 Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease Daniel W. Kneller, Hui Li, Gwyndalyn Phillips, Kevin L. Weiss, Qiu Zhang, Mark A. Arnould, et al. (+8)
397 [GO] 2022―Apr―25 Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2 Ma’ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, et al. (+13)
398 [GO] 2022―Apr―22 Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel Jacob G. Waxman, Maya Makov-Assif, Ben Y. Reis, Doron Netzer, Ran D. Balicer, Noa Dagan, Noam Barda
399 [GO] 2022―Apr―21 App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden Beatrice Kennedy, Hugo Fitipaldi, Ulf Hammar, Marlena Maziarz, Neli Tsereteli, Nikolay Oskolkov, et al. (+30)
400 [GO] 2022―Apr―19 Accelerated biological aging in COVID-19 patients Xue Cao, Wenjuan Li, Ting Wang, Dongzhi Ran, Veronica Davalos, Laura Planas-Serra, et al. (+4)
401 [GO] 2022―Apr―19 Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model Qizhou Lian, Kui Zhang, Zhao Zhang, Fuyu Duan, Liyan Guo, Weiren Luo, et al. (+26)
402 [GO] 2022―Apr―13 Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventions Simon Arsène, Claire Couty, Igor Faddeenkov, Natacha Go, Solène Granjeon-Noriot, Daniel Šmít, et al. (+7)
403 [GO] 2022―Apr―12 Persistent COVID-19 symptoms in a community study of 606,434 people in England Matthew Whitaker, Joshua Elliott, Marc Chadeau-Hyam, Steven Riley, Ara Darzi, Graham Cooke, et al. (+2)
404 [GO] 2022―Apr―12 Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events Rachael Pung, Josh A. Firth, Lewis G. Spurgin, Annie Chang, Jade Kong, Jazzy Wong, et al. (+54)
405 [GO] 2022―Apr―12 Author Correction: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies Fortunato Ferrara, M. Frank Erasmus, Sara D’Angelo, Camila Leal-Lopes, André A. Teixeira, Alok Choudhary, et al. (+9)
406 [GO] 2022―Apr―08 Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage Cathrine Scheepers, Josie Everatt, Daniel G. Amoako, Houriiyah Tegally, Constantinos Kurt Wibmer, Anele Mnguni, et al. (+39)
407 [GO] 2022―Apr―07 Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19 Hengrui Liu, Sho Iketani, Arie Zask, Nisha Khanizeman, Eva Bednarova, Farhad Forouhar, et al. (+26)
408 [GO] 2022―Apr―06 Author Correction: National identity predicts public health support during a global pandemic Jay J. Van Bavel, Aleksandra Cichocka, Valerio Capraro, Hallgeir Sjåstad, John B. Nezlek, Tomislav Pavlović, et al. (+251)
409 [GO] 2022―Apr―05 Group testing via hypergraph factorization applied to COVID-19 David Hong, Rounak Dey, Xihong Lin, Brian Cleary, Edgar Dobriban
410 [GO] 2022―Apr―05 Black carbon-climate interactions regulate dust burdens over India revealed during COVID-19 Linyi Wei, Zheng Lu, Yong Wang, Xiaohong Liu, Weiyi Wang, Chenglai Wu, et al. (+4)
411 [GO] 2022―Apr―05 Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort Viet-Thi Tran, Raphaël Porcher, Isabelle Pane, Philippe Ravaud
412 [GO] 2022―Apr―04 Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern Xiaoqi Yu, Dong Wei, Wenxin Xu, Chuanmiao Liu, Wentian Guo, Xinxin Li, et al. (+6)
413 [GO] 2022―Apr―01 Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates Ibolya Rutkai, Meredith G. Mayer, Linh M. Hellmers, Bo Ning, Zhen Huang, Christopher J. Monjure, et al. (+16)
414 [GO] 2022―Mar―31 Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination Vijaykrishna Dhanasekaran, Sheena Sullivan, Kimberly M. Edwards, Ruopeng Xie, Arseniy Khvorov, Sophie A. Valkenburg, et al. (+2)
415 [GO] 2022―Mar―31 Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G. Anosova, Dean Huang, Tim Tibbitts, et al. (+6)
416 [GO] 2022―Mar―30 Publisher Correction: Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater Davida S. Smyth, Monica Trujillo, Devon A. Gregory, Kristen Cheung, Anna Gao, Maddie Graham, et al. (+16)
417 [GO] 2022―Mar―28 Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617 Lei Peng, Yingxia Hu, Madeleine C. Mankowski, Ping Ren, Rita E. Chen, Jin Wei, et al. (+18)
418 [GO] 2022―Mar―28 Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors Laura Pérez-Alós, Jose Juan Almagro Armenteros, Johannes Roth Madsen, Cecilie Bo Hansen, Ida Jarlhelt, Sebastian Rask Hamm, et al. (+17)
419 [GO] 2022―Mar―25 Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19 Tanja Paul, Stephan Ledderose, Harald Bartsch, Na Sun, Sarah Soliman, Bruno Märkl, et al. (+18)
420 [GO] 2022―Mar―25 Author Correction: Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom Long H. Nguyen, Amit D. Joshi, David A. Drew, Jordi Merino, Wenjie Ma, Chun-Han Lo, et al. (+19)
421 [GO] 2022―Mar―25 Ultrastructural insight into SARS-CoV-2 entry and budding in human airway epithelium Andreia L. Pinto, Ranjit K. Rai, Jonathan C. Brown, Paul Griffin, James R. Edgar, Anand Shah, et al. (+5)
422 [GO] 2022―Mar―25 MERS-CoV ORF4b employs an unusual binding mechanism to target IMPα and block innate immunity Thilini S. Munasinghe, Megan R. Edwards, Sofiya Tsimbalyuk, Olivia A. Vogel, Kate M. Smith, Murray Stewart, et al. (+6)
423 [GO] 2022―Mar―21 Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50 Junqing Xie, Shuo Feng, Xintong Li, Ester Gea-Mallorquí, Albert Prats-Uribe, Dani Prieto-Alhambra
424 [GO] 2022―Mar―17 Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19 Benjamin Faucher, Rania Assab, Jonathan Roux, Daniel Levy-Bruhl, Cécile Tran Kiem, Simon Cauchemez, et al. (+4)
425 [GO] 2022―Mar―17 RNA G-quadruplex in TMPRSS2 reduces SARS-CoV-2 infection Geng Liu, Wenya Du, Xiongbo Sang, Qiyu Tong, Ye Wang, Guoqing Chen, et al. (+6)
426 [GO] 2022―Mar―17 De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report Shiv Gandhi, Jonathan Klein, Alexander J. Robertson, Mario A. Peña-Hernández, Michelle J. Lin, Pavitra Roychoudhury, et al. (+17)
427 [GO] 2022―Mar―16 Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin, Diana Muñoz Sandoval, Catherine J. Reynolds, Rocio Castro Seoane, et al. (+564)
428 [GO] 2022―Mar―11 Publisher Correction: Abrupt emissions reductions during COVID-19 contributed to record summer rainfall in China Yang Yang, Lili Ren, Mingxuan Wu, Hailong Wang, Fengfei Song, L. Ruby Leung, et al. (+10)
429 [GO] 2022―Mar―10 Divergent trajectories of antiviral memory after SARS-CoV-2 infection Adriana Tomic, Donal T. Skelly, Ane Ogbe, Daniel O’Connor, Matthew Pace, Emily Adland, et al. (+102)
430 [GO] 2022―Mar―09 Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity Otavio Cabral-Marques, Gilad Halpert, Lena F. Schimke, Yuri Ostrinski, Aristo Vojdani, Gabriela Crispim Baiocchi, et al. (+30)
431 [GO] 2022―Mar―04 COVID-19, Green Deal and recovery plan permanently change emissions and prices in EU ETS Phase IV Kenneth Bruninx, Marten Ovaere
432 [GO] 2022―Mar―04 The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers’ unvaccinated household members Jussipekka Salo, Milla Hägg, Mika Kortelainen, Tuija Leino, Tanja Saxell, Markku Siikanen, Lauri Sääksvuori
433 [GO] 2022―Mar―04 Waning of SARS-CoV-2 booster viral-load reduction effectiveness Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Esma Herzel, Jacob Kuint, Gabriel Chodick, et al. (+3)
434 [GO] 2022―Mar―04 Evolution of the SARS-CoV-2 spike protein in the human host Antoni G. Wrobel, Donald J. Benton, Chloë Roustan, Annabel Borg, Saira Hussain, Stephen R. Martin, et al. (+3)
435 [GO] 2022―Mar―03 Incorporating temporal distribution of population-level viral load enables real-time estimation of COVID-19 transmission Yun Lin, Bingyi Yang, Sarah Cobey, Eric H. Y. Lau, Dillon C. Adam, Jessica Y. Wong, et al. (+10)
436 [GO] 2022―Mar―03 Antibody escape and global spread of SARS-CoV-2 lineage A.27 Tamara Kaleta, Lisa Kern, Samuel Leandro Hong, Martin Hölzer, Georg Kochs, Julius Beer, et al. (+27)
437 [GO] 2022―Mar―03 Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain Gang Ye, Bin Liu, Fang Li
438 [GO] 2022―Mar―02 Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells Tammy C. T. Lan, Matty F. Allan, Lauren E. Malsick, Jia Z. Woo, Chi Zhu, Fengrui Zhang, et al. (+8)
439 [GO] 2022―Mar―01 Quantifying pupil-to-pupil SARS-CoV-2 transmission and the impact of lateral flow testing in English secondary schools Trystan Leng, Edward M. Hill, Alex Holmes, Emma Southall, Robin N. Thompson, Michael J. Tildesley, et al. (+2)
440 [GO] 2022―Feb―28 Population-scale dietary interests during the COVID-19 pandemic Kristina Gligorić, Arnaud Chiolero, Emre Kıcıman, Ryen W. White, Robert West
441 [GO] 2022―Feb―23 Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission Dinesh Aggarwal, Andrew J. Page, Ulf Schaefer, George M. Savva, Richard Myers, Erik Volz, et al. (+599)
442 [GO] 2022―Feb―23 Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection Kami Pekayvaz, Alexander Leunig, Rainer Kaiser, Markus Joppich, Sophia Brambs, Aleksandar Janjic, et al. (+38)
443 [GO] 2022―Feb―22 Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core Alexander J. Pak, Alvin Yu, Zunlong Ke, John A. G. Briggs, Gregory A. Voth
444 [GO] 2022―Feb―18 Abrupt emissions reductions during COVID-19 contributed to record summer rainfall in China Yang Yang, Lili Ren, Mingxuan Wu, Hailong Wang, Fengfei Song, L. Ruby Leung, et al. (+10)
445 [GO] 2022―Feb―17 Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications Maryam A. Y. Al-Nesf, Houari B. Abdesselem, Ilham Bensmail, Shahd Ibrahim, Walaa A. H. Saeed, Sara S. I. Mohammed, et al. (+20)
446 [GO] 2022―Feb―17 Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning Yvonne M. Mueller, Thijs J. Schrama, Rik Ruijten, Marco W. J. Schreurs, Dwin G. B. Grashof, Harmen J. G. van de Werken, et al. (+22)
447 [GO] 2022―Feb―17 Publisher Correction: Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves Benjamin B. Lindsey, Ch. Julián Villabona-Arenas, Finlay Campbell, Alexander J. Keeley, Matthew D. Parker, Dhruv R. Shah, et al. (+51)
448 [GO] 2022―Feb―16 Population antibody responses following COVID-19 vaccination in 212,102 individuals Helen Ward, Matthew Whitaker, Barnaby Flower, Sonja N. Tang, Christina Atchison, Ara Darzi, et al. (+8)
449 [GO] 2022―Feb―15 Cell specific peripheral immune responses predict survival in critical COVID-19 patients Junedh M. Amrute, Alexandra M. Perry, Gautam Anand, Carlos Cruchaga, Karl G. Hock, Christopher W. Farnsworth, et al. (+3)
450 [GO] 2022―Feb―15 Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies Yifan Wang, Caixuan Liu, Chao Zhang, Yanxing Wang, Qin Hong, Shiqi Xu, et al. (+4)
451 [GO] 2022―Feb―15 The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern Rana Abdelnabi, Caroline S. Foo, Dirk Jochmans, Laura Vangeel, Steven De Jonghe, Patrick Augustijns, et al. (+11)
452 [GO] 2022―Feb―14 AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic Tuyet Hoang, Anders Gonçalves da Silva, Amy V. Jennison, Deborah A. Williamson, Benjamin P. Howden, Torsten Seemann
453 [GO] 2022―Feb―14 Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies Daniel Re, Barbara Seitz-Polski, Vesna Brglez, Michel Carles, Daisy Graça, Sylvia Benzaken, et al. (+7)
454 [GO] 2022―Feb―14 Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein Oskar Staufer, Kapil Gupta, Jochen Estebano Hernandez Bücher, Fabian Kohler, Christian Sigl, Gunjita Singh, et al. (+11)
455 [GO] 2022―Feb―09 Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection Jing Zou, Hongjie Xia, Xuping Xie, Chaitanya Kurhade, Rafael R. G. Machado, Scott C. Weaver, et al. (+2)
456 [GO] 2022―Feb―08 Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission Dinesh Aggarwal, Ben Warne, Aminu S. Jahun, William L. Hamilton, Thomas Fieldman, Louis du Plessis, et al. (+722)
457 [GO] 2022―Feb―08 Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong Haogao Gu, Ruopeng Xie, Dillon C. Adam, Joseph L.-H. Tsui, Daniel K. Chu, Lydia D. J. Chang, et al. (+17)
458 [GO] 2022―Feb―08 Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants James W. Saville, Dhiraj Mannar, Xing Zhu, Shanti S. Srivastava, Alison M. Berezuk, Jean-Philippe Demers, et al. (+7)
459 [GO] 2022―Feb―03 Myeloid cell interferon responses correlate with clearance of SARS-CoV-2 Dhiraj K. Singh, Ekaterina Aladyeva, Shibali Das, Bindu Singh, Ekaterina Esaulova, Amanda Swain, et al. (+8)
460 [GO] 2022―Feb―03 Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater Davida S. Smyth, Monica Trujillo, Devon A. Gregory, Kristen Cheung, Anna Gao, Maddie Graham, et al. (+16)
461 [GO] 2022―Feb―03 Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria Egon A. Ozer, Lacy M. Simons, Olubusuyi M. Adewumi, Adeola A. Fowotade, Ewean C. Omoruyi, Johnson A. Adeniji, et al. (+14)
462 [GO] 2022―Feb―03 Characterising within-hospitalSARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves Benjamin B. Lindsey, Ch. Julián Villabona-Arenas, Finlay Campbell, Alexander J. Keeley, Matthew D. Parker, Dhruv R. Shah, et al. (+51)
463 [GO] 2022―Feb―02 A population-based cohort study of obesity, ethnicity and COVID-19 mortality in 12.6 million adults in England Thomas Yates, Annabel Summerfield, Cameron Razieh, Amitava Banerjee, Yogini Chudasama, Melanie J. Davies, et al. (+7)
464 [GO] 2022―Feb―02 Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England Gayatri Amirthalingam, Jamie Lopez Bernal, Nick J. Andrews, Heather Whitaker, Charlotte Gower, Julia Stowe, et al. (+12)
465 [GO] 2022―Feb―02 A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase Ashleigh Shannon, Véronique Fattorini, Bhawna Sama, Barbara Selisko, Mikael Feracci, Camille Falcou, et al. (+17)
466 [GO] 2022―Feb―01 Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom Long H. Nguyen, Amit D. Joshi, David A. Drew, Jordi Merino, Wenjie Ma, Chun-Han Lo, et al. (+19)
467 [GO] 2022―Feb―01 Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico Ana Basto-Abreu, Martha Carnalla, Leticia Torres-Ibarra, Martín Romero-Martínez, Jesús Martínez-Barnetche, Irma López-Martínez, et al. (+19)
468 [GO] 2022―Feb―01 SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load Tobias Mourier, Muhammad Shuaib, Sharif Hala, Sara Mfarrej, Fadwa Alofi, Raeece Naeem, et al. (+30)
469 [GO] 2022―Feb―01 Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot Jörg Paetzold, Janine Kimpel, Katie Bates, Michael Hummer, Florian Krammer, Dorothee von Laer, Hannes Winner
470 [GO] 2022―Jan―27 Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools using agent-based simulations and cluster tracing data Jana Lasser, Johannes Sorger, Lukas Richter, Stefan Thurner, Daniela Schmid, Peter Klimek
471 [GO] 2022―Jan―27 Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections Laith J. Abu-Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, Peter Coyle, Mohammad R. Hasan, et al. (+17)
472 [GO] 2022―Jan―26 National identity predicts public health support during a global pandemic Jay J. Van Bavel, Aleksandra Cichocka, Valerio Capraro, Hallgeir Sjåstad, John B. Nezlek, Tomislav Pavlović, et al. (+251)
473 [GO] 2022―Jan―25 Regional excess mortality during the 2020 COVID-19 pandemic in five European countries Garyfallos Konstantinoudis, Michela Cameletti, Virgilio Gómez-Rubio, Inmaculada León Gómez, Monica Pirani, Gianluca Baio, et al. (+5)
474 [GO] 2022―Jan―25 Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Tala Ballouz, Dominik Menges, Sara Hasler, et al. (+10)
475 [GO] 2022―Jan―24 Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant Baisheng Li, Aiping Deng, Kuibiao Li, Yao Hu, Zhencui Li, Yaling Shi, et al. (+40)
476 [GO] 2022―Jan―24 A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies Fortunato Ferrara, M. Frank Erasmus, Sara D’Angelo, Camila Leal-Lopes, André A. Teixeira, Alok Choudhary, et al. (+9)
477 [GO] 2022―Jan―21 Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19 Avraham Unterman, Tomokazu S. Sumida, Nima Nouri, Xiting Yan, Amy Y. Zhao, Victor Gasque, et al. (+46)
478 [GO] 2022―Jan―21 Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response time Claudia E. Vickers, Paul S. Freemont
479 [GO] 2022―Jan―20 Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong Francisco Tsz Tsun Lai, Lei Huang, Celine Sze Ling Chui, Eric Yuk Fai Wan, Xue Li, Carlos King Ho Wong, et al. (+7)
480 [GO] 2022―Jan―20 Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2 Lamiaa El-Shennawy, Andrew D. Hoffmann, Nurmaa Khund Dashzeveg, Kathleen M. McAndrews, Paul J. Mehl, Daphne Cornish, et al. (+30)
481 [GO] 2022―Jan―19 A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, et al. (+32)
482 [GO] 2022―Jan―18 Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2 Valeria Garcia-Flores, Roberto Romero, Yi Xu, Kevin R. Theis, Marcia Arenas-Hernandez, Derek Miller, et al. (+18)
483 [GO] 2022―Jan―14 Model-based evaluation of alternative reactive class closure strategies against COVID-19 Quan-Hui Liu, Juanjuan Zhang, Cheng Peng, Maria Litvinova, Shudong Huang, Piero Poletti, et al. (+11)
484 [GO] 2022―Jan―12 Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation Haibo Wu, Peiqi He, Yong Ren, Shiqi Xiao, Wei Wang, Zhenbang Liu, et al. (+17)
485 [GO] 2022―Jan―11 Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2 Kapil Gupta, Christine Toelzer, Maia Kavanagh Williamson, Deborah K. Shoemark, A. Sofia F. Oliveira, David A. Matthews, et al. (+11)
486 [GO] 2022―Jan―11 Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk David R. M. Smith, Audrey Duval, Jean Ralph Zahar, Niels Hendrickx, Kévin Jean, Sofía Jijón, et al. (+5)
487 [GO] 2022―Jan―11 Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies Jeremy R. Keown, Zihan Zhu, Loïc Carrique, Haitian Fan, Alexander P. Walker, Itziar Serna Martin, et al. (+4)
488 [GO] 2022―Jan―10 Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges João Faro-Viana, Marie-Louise Bergman, Lígia A. Gonçalves, Nádia Duarte, Teresa P. Coutinho, Patrícia C. Borges, et al. (+14)
489 [GO] 2022―Jan―10 Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts Rhia Kundu, Janakan Sam Narean, Lulu Wang, Joseph Fenn, Timesh Pillay, Nieves Derqui Fernandez, et al. (+17)
490 [GO] 2022―Jan―10 Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents Nina Koerber, Alina Priller, Sarah Yazici, Tanja Bauer, Cho-Chin Cheng, Hrvoje Mijočević, et al. (+19)
491 [GO] 2022―Jan―10 A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo Leo Hanke, Hrishikesh Das, Daniel J. Sheward, Laura Perez Vidakovics, Egon Urgard, Ainhoa Moliner-Morro, et al. (+12)
492 [GO] 2022―Jan―10 Robust and durable serological response following pediatric SARS-CoV-2 infection Hanna Renk, Alex Dulovic, Alina Seidel, Matthias Becker, Dorit Fabricius, Maria Zernickel, et al. (+44)
493 [GO] 2022―Jan―10 Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets Young-Il Kim, Kwang-Min Yu, June-Young Koh, Eun-Ha Kim, Se-Mi Kim, Eun Ji Kim, et al. (+15)
494 [GO] 2022―Jan―10 Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors Daichao Wu, Alexander Kolesnikov, Rui Yin, Johnathan D. Guest, Ragul Gowthaman, Anton Shmelev, et al. (+5)
495 [GO] 2021―Dec―20 Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM Yifan Wang, Cong Xu, Yanxing Wang, Qin Hong, Chao Zhang, Zuyang Li, et al. (+5)
496 [GO] 2021―Dec―16 Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography Obinna C. Ubah, Eric W. Lake, Gihan S. Gunaratne, Joseph P. Gallant, Marie Fernie, Austin J. Robertson, et al. (+15)
497 [GO] 2021―Dec―16 Author Correction: Development of a model-inference system for estimating epidemiological characteristics of SARS-CoV-2 variants of concern Wan Yang, Jeffrey Shaman
498 [GO] 2021―Dec―14 The effect of COVID-19 vaccination in Italy and perspectives for living with the virus Valentina Marziano, Giorgio Guzzetta, Alessia Mammone, Flavia Riccardo, Piero Poletti, Filippo Trentini, et al. (+9)
499 [GO] 2021―Dec―14 A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults Miwa Haranaka, James Baber, Yoichiro Ogama, Masako Yamaji, Masakazu Aizawa, Osamu Kogawara, et al. (+7)
500 [GO] 2021―Dec―14 Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation Keisuke Tabata, Vibhu Prasad, David Paul, Ji-Young Lee, Minh-Tu Pham, Woan-Ing Twu, et al. (+20)
501 [GO] 2021―Dec―14 Estimating the strength of selection for new SARS-CoV-2 variants Christiaan H. van Dorp, Emma E. Goldberg, Nick Hengartner, Ruian Ke, Ethan O. Romero-Severson
502 [GO] 2021―Dec―13 Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load Frederik Plesner Lyngse, Kåre Mølbak, Robert Leo Skov, Lasse Engbo Christiansen, Laust Hvas Mortensen, Mads Albertsen, et al. (+105)
503 [GO] 2021―Dec―10 Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England Gayatri Amirthalingam, Jamie Lopez Bernal, Nick J. Andrews, Heather Whitaker, Charlotte Gower, Julia Stowe, et al. (+12)
504 [GO] 2021―Dec―10 The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting Matthias M. Zimmer, Anuja Kibe, Ulfert Rand, Lukas Pekarek, Liqing Ye, Stefan Buck, et al. (+3)
505 [GO] 2021―Dec―09 Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19 Masako Nishikawa, Hiroshi Kanno, Yuqi Zhou, Ting-Hui Xiao, Takuma Suzuki, Yuma Ibayashi, et al. (+18)
506 [GO] 2021―Dec―07 Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2 Catherine F. Hatton, Rachel A. Botting, Maria Emilia Dueñas, Iram J. Haq, Bernard Verdon, Benjamin J. Thompson, et al. (+22)
507 [GO] 2021―Dec―03 Modeling serological testing to inform relaxation of social distancing for COVID-19 control Alicia N. M. Kraay, Kristin N. Nelson, Conan Y. Zhao, David Demory, Joshua S. Weitz, Benjamin A. Lopman
508 [GO] 2021―Dec―01 Publisher Correction: Standardized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA Aravind Natarajan, Alvin Han, Soumaya Zlitni, Erin F. Brooks, Summer E. Vance, Marlene Wolfe, et al. (+5)
509 [GO] 2021―Nov―30 Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants Melanie Koehler, Ankita Ray, Rodrigo A. Moreira, Blinera Juniku, Adolfo B. Poma, David Alsteens
510 [GO] 2021―Nov―26 Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic Meng-Jie Geng, Hai-Yang Zhang, Lin-Jie Yu, Chen-Long Lv, Tao Wang, Tian-Le Che, et al. (+10)
511 [GO] 2021―Nov―26 Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization Dennis Lapuente, Jana Fuchs, Jonas Willar, Ana Vieira Antão, Valentina Eberlein, Nadja Uhlig, et al. (+17)
512 [GO] 2021―Nov―25 Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response Jonathan D. Herman, Chuangqi Wang, Carolin Loos, Hyunah Yoon, Johanna Rivera, M. Eugenia Dieterle, et al. (+9)
513 [GO] 2021―Nov―25 Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses Tiago Fazolo, Karina Lima, Julia C. Fontoura, Priscila Oliveira de Souza, Gabriel Hilario, Renata Zorzetto, et al. (+25)
514 [GO] 2021―Nov―25 Spike residue 403 affects binding of coronavirus spikes to human ACE2 Fabian Zech, Daniel Schniertshauer, Christoph Jung, Alexandra Herrmann, Arne Cordsmeier, Qinya Xie, et al. (+16)
515 [GO] 2021―Nov―25 SARS-CoV-2 transmission across age groups in France and implications for control Cécile Tran Kiem, Paolo Bosetti, Juliette Paireau, Pascal Crépey, Henrik Salje, Noémie Lefrancq, et al. (+6)
516 [GO] 2021―Nov―23 Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands Lu Lu, Reina S. Sikkema, Francisca C. Velkers, David F. Nieuwenhuijse, Egil A. J. Fischer, Paola A. Meijer, et al. (+18)
517 [GO] 2021―Nov―23 ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury Tomokazu Yamaguchi, Midori Hoshizaki, Takafumi Minato, Satoru Nirasawa, Masamitsu N. Asaka, Mayumi Niiyama, et al. (+24)
518 [GO] 2021―Nov―19 COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types Benjamin J. Schmiedel, Job Rocha, Cristian Gonzalez-Colin, Sourya Bhattacharyya, Ariel Madrigal, Christian H. Ottensmeier, et al. (+3)
519 [GO] 2021―Nov―19 Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities Thomas Kruse, Caroline Benz, Dimitriya H. Garvanska, Richard Lindqvist, Filip Mihalic, Fabian Coscia, et al. (+16)
520 [GO] 2021―Nov―18 Jumper enables discontinuous transcript assembly in coronaviruses Palash Sashittal, Chuanyi Zhang, Jian Peng, Mohammed El-Kebir
521 [GO] 2021―Nov―18 Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity Irene A. Abela, Chloé Pasin, Magdalena Schwarzmüller, Selina Epp, Michèle E. Sickmann, Merle M. Schanz, et al. (+25)
522 [GO] 2021―Nov―16 Organ-specific genome diversity of replication-competent SARS-CoV-2 Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts, Amélie Dendooven, Valentino D’Onofrio, Liesbeth Couck, et al. (+17)
523 [GO] 2021―Nov―16 SARS-CoV-2 infection and replication in human gastric organoids Giovanni Giuseppe Giobbe, Francesco Bonfante, Brendan C. Jones, Onelia Gagliano, Camilla Luni, Elisa Zambaiti, et al. (+19)
524 [GO] 2021―Nov―15 SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis Ji-Seung Yoo, Michihito Sasaki, Steven X. Cho, Yusuke Kasuga, Baohui Zhu, Ryota Ouda, et al. (+4)
525 [GO] 2021―Nov―12 Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status Yan Xie, Benjamin Bowe, Ziyad Al-Aly
526 [GO] 2021―Nov―12 SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains Peter Radvak, Hyung-Joon Kwon, Martina Kosikova, Uriel Ortega-Rodriguez, Ruoxuan Xiang, Je-Nie Phue, et al. (+6)
527 [GO] 2021―Nov―11 Diverse integrated ecosystem approach overcomes pandemic-related fisheries monitoring challenges Jarrod A. Santora, Tanya L. Rogers, Megan A. Cimino, Keith M. Sakuma, Keith D. Hanson, E. J. Dick, et al. (+3)
528 [GO] 2021―Nov―09 A novel SARS-CoV-2 related coronavirus in bats from Cambodia Deborah Delaune, Vibol Hul, Erik A. Karlsson, Alexandre Hassanin, Tey Putita Ou, Artem Baidaliuk, et al. (+12)
529 [GO] 2021―Nov―08 Spatiotemporal prediction of COVID-19 cases using inter- and intra-county proxies of human interactions Behzad Vahedi, Morteza Karimzadeh, Hamidreza Zoraghein
530 [GO] 2021―Nov―05 Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets Robert M. Cox, Josef D. Wolf, Carolin M. Lieber, Julien Sourimant, Michelle J. Lin, Darius Babusis, et al. (+13)
531 [GO] 2021―Nov―04 Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants Sebastian Weigang, Jonas Fuchs, Gert Zimmer, Daniel Schnepf, Lisa Kern, Julius Beer, et al. (+17)
532 [GO] 2021―Nov―04 Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine Barak Mizrahi, Roni Lotan, Nir Kalkstein, Asaf Peretz, Galit Perez, Amir Ben-Tov, et al. (+3)
533 [GO] 2021―Nov―04 Potential global impacts of alternative dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine Ricardo Aguas, Anouska Bharath, Lisa J. White, Bo Gao, Andrew J. Pollard, Merryn Voysey, Rima Shretta
534 [GO] 2021―Nov―02 Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants Tingting Li, Xiaojian Han, Chenjian Gu, Hangtian Guo, Huajun Zhang, Yingming Wang, et al. (+40)
535 [GO] 2021―Nov―01 A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters Phanramphoei N. Frantz, Aleksandr Barinov, Claude Ruffié, Chantal Combredet, Valérie Najburg, Guilherme Dias de Melo, et al. (+18)
536 [GO] 2021―Nov―01 Understanding how Victoria, Australia gained control of its second COVID-19 wave James M. Trauer, Michael J. Lydeamore, Gregory W. Dalton, David Pilcher, Michael T. Meehan, Emma S. McBryde, et al. (+3)
537 [GO] 2021―Oct―29 Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host Verónica Lloréns-Rico, Ann C. Gregory, Johan Van Weyenbergh, Sander Jansen, Tina Van Buyten, Junbin Qian, et al. (+21)
538 [GO] 2021―Oct―29 Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa Krishna P. Reddy, Kieran P. Fitzmaurice, Justine A. Scott, Guy Harling, Richard J. Lessells, Christopher Panella, et al. (+3)
539 [GO] 2021―Oct―29 Anti-spike antibody response to natural SARS-CoV-2 infection in the general population Jia Wei, Philippa C. Matthews, Nicole Stoesser, Thomas Maddox, Luke Lorenzi, Ruth Studley, et al. (+74)
540 [GO] 2021―Oct―28 Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo Matt D. T. Hitchings, Otavio T. Ranzani, Murilo Dorion, Tatiana Lang D’Agostini, Regiane Cardoso de Paula, Olivia Ferreira Pereira de Paula, et al. (+14)
541 [GO] 2021―Oct―28 A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries Francesco Sera, Ben Armstrong, Sam Abbott, Sophie Meakin, Kathleen O’Reilly, Rosa von Borries, et al. (+92)
542 [GO] 2021―Oct―27 A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses Weina Sun, Yonghong Liu, Fatima Amanat, Irene González-Domínguez, Stephen McCroskery, Stefan Slamanig, et al. (+19)
543 [GO] 2021―Oct―26 Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels C. Bottomley, M. Otiende, S. Uyoga, K. Gallagher, E. W. Kagucia, A. O. Etyang, et al. (+9)
544 [GO] 2021―Oct―26 Potentially long-lasting effects of the pandemic on scientists Jian Gao, Yian Yin, Kyle R. Myers, Karim R. Lakhani, Dashun Wang
545 [GO] 2021―Oct―20 COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models Pauline Maisonnasse, Yoann Aldon, Aurélien Marc, Romain Marlin, Nathalie Dereuddre-Bosquet, Natalia A. Kuzmina, et al. (+45)
546 [GO] 2021―Oct―20 Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants Pengcheng Han, Chao Su, Yanfang Zhang, Chongzhi Bai, Anqi Zheng, Chengpeng Qiao, et al. (+18)
547 [GO] 2021―Oct―18 Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 Britton Boras, Rhys M. Jones, Brandon J. Anson, Dan Arenson, Lisa Aschenbrenner, Malina A. Bakowski, et al. (+46)
548 [GO] 2021―Oct―15 SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers Francesca Rovida, Irene Cassaniti, Stefania Paolucci, Elena Percivalle, Antonella Sarasini, Antonio Piralla, et al. (+16)
549 [GO] 2021―Oct―14 Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020 Maureen Rebecca Smith, Maria Trofimova, Ariane Weber, Yannick Duport, Denise Kühnert, Max von Kleist
550 [GO] 2021―Oct―13 Clonal hematopoiesis is associated with risk of severe Covid-19 Kelly L. Bolton, Youngil Koh, Michael B. Foote, Hogune Im, Justin Jee, Choong Hyun Sun, et al. (+39)
551 [GO] 2021―Oct―08 SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon Kene Nwosu, Joseph Fokam, Franck Wanda, Lucien Mama, Erol Orel, Nicolas Ray, et al. (+9)
552 [GO] 2021―Oct―08 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil Sue Ann Costa Clemens, Pedro M. Folegatti, Katherine R. W. Emary, Lily Yin Weckx, Jeremy Ratcliff, Sagida Bibi, et al. (+120)
553 [GO] 2021―Oct―07 ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 Robert J. Fischer, Neeltje van Doremalen, Danielle R. Adney, Claude Kwe Yinda, Julia R. Port, Myndi G. Holbrook, et al. (+14)
554 [GO] 2021―Oct―07 SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques Ramon Roozendaal, Laura Solforosi, Daniel J. Stieh, Jan Serroyen, Roel Straetemans, Anna Dari, et al. (+20)
555 [GO] 2021―Oct―05 Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe Mrinank Sharma, Sören Mindermann, Charlie Rogers-Smith, Gavin Leech, Benedict Snodin, Janvi Ahuja, et al. (+18)
556 [GO] 2021―Oct―05 Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity Hagit Achdout, Einat. B. Vitner, Boaz Politi, Sharon Melamed, Yfat Yahalom-Ronen, Hadas Tamir, et al. (+12)
557 [GO] 2021―Oct―05 Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV Aljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, Dan Hameiri-Bowen, Jakub Kopycinski, Bethany Charlton, et al. (+15)
558 [GO] 2021―Oct―04 Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection Marion Ferren, Valérie Favède, Didier Decimo, Mathieu Iampietro, Nicole A. P. Lieberman, Jean-Luc Weickert, et al. (+9)
559 [GO] 2021―Oct―01 Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions Gytis Dudas, Samuel L. Hong, Barney I. Potter, Sébastien Calvignac-Spencer, Frédéric S. Niatou-Singa, Thais B. Tombolomako, et al. (+64)
560 [GO] 2021―Oct―01 Standardized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA Aravind Natarajan, Alvin Han, Soumaya Zlitni, Erin F. Brooks, Summer E. Vance, Marlene Wolfe, et al. (+5)
561 [GO] 2021―Sep―30 Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics Louise Dyson, Edward M. Hill, Sam Moore, Jacob Curran-Sebastian, Michael J. Tildesley, Katrina A. Lythgoe, et al. (+3)
562 [GO] 2021―Sep―29 Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity Yvan Butera, Enatha Mukantwari, Maria Artesi, Jeanne d’arc Umuringa, Áine Niamh O’Toole, Verity Hill, et al. (+30)
563 [GO] 2021―Sep―28 In vivo structure and dynamics of the SARS-CoV-2 RNA genome Yan Zhang, Kun Huang, Dejian Xie, Jian You Lau, Wenlong Shen, Ping Li, et al. (+9)
564 [GO] 2021―Sep―27 Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 Shihui Sun, Hongjing Gu, Lei Cao, Qi Chen, Qing Ye, Guan Yang, et al. (+24)
565 [GO] 2021―Sep―27 Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants Tingting Li, Wenhui Xue, Qingbing Zheng, Shuo Song, Chuanlai Yang, Hualong Xiong, et al. (+25)
566 [GO] 2021―Sep―27 Author Correction: Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection Sara De Biasi, Domenico Lo Tartaro, Lara Gibellini, Annamaria Paolini, Andrew Quong, Carlene Petes, et al. (+20)
567 [GO] 2021―Sep―23 SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms Janeri Fröberg, Joshua Gillard, Ria Philipsen, Kjerstin Lanke, Joyce Rust, Diana van Tuijl, et al. (+13)
568 [GO] 2021―Sep―22 A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 Jiandong Huo, Halina Mikolajek, Audrey Le Bas, Jordan J. Clark, Parul Sharma, Anja Kipar, et al. (+27)
569 [GO] 2021―Sep―22 Development of a model-inference system for estimating epidemiological characteristics of SARS-CoV-2 variants of concern Wan Yang, Jeffrey Shaman
570 [GO] 2021―Sep―21 Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential Bjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt, Philip Brownridge, Dominic P. Bryne, Leonard A. Daly, et al. (+13)
571 [GO] 2021―Sep―20 Multi-level inhibition of coronavirus replication by chemical ER stress Mohammed Samer Shaban, Christin Müller, Christin Mayr-Buro, Hendrik Weiser, Johanna Meier-Soelch, Benadict Vincent Albert, et al. (+11)
572 [GO] 2021―Sep―17 A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses Joep Beumer, Maarten H. Geurts, Mart M. Lamers, Jens Puschhof, Jingshu Zhang, Jelte van der Vaart, et al. (+10)
573 [GO] 2021―Sep―17 A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies Xun Chen, Matteo Gentili, Nir Hacohen, Aviv Regev
574 [GO] 2021―Sep―14 New-onset IgG autoantibodies in hospitalized patients with COVID-19 Sarah Esther Chang, Allan Feng, Wenzhao Meng, Sokratis A. Apostolidis, Elisabeth Mack, Maja Artandi, et al. (+43)
575 [GO] 2021―Sep―13 Contact tracing is an imperfect tool for controlling COVID-19 transmission and relies on population adherence Emma L. Davis, Tim C. D. Lucas, Anna Borlase, Timothy M. Pollington, Sam Abbott, Diepreye Ayabina, et al. (+55)
576 [GO] 2021―Sep―13 The SARS-CoV-2 spike protein is vulnerable to moderate electric fields Claudia R. Arbeitman, Pablo Rojas, Pedro Ojeda-May, Martin E. Garcia
577 [GO] 2021―Sep―09 Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation Jérôme Cattin-Ortolá, Lawrence G. Welch, Sarah L. Maslen, Guido Papa, Leo C. James, Sean Munro
578 [GO] 2021―Sep―01 Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques Romain Marlin, Veronique Godot, Sylvain Cardinaud, Mathilde Galhaut, Severin Coleon, Sandra Zurawski, et al. (+32)
579 [GO] 2021―Aug―31 Author Correction: SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation Pan Pan, Miaomiao Shen, Zhenyang Yu, Weiwei Ge, Keli Chen, Mingfu Tian, et al. (+16)
580 [GO] 2021―Aug―30 The COVID-19 pandemic as a pivot point for biological conservation Amanda E. Bates, Sangeeta Mangubhai, Celene B. Milanés, Ku’ulei Rodgers, Valeria Vergara
581 [GO] 2021―Aug―27 A pre-registered short-term forecasting study of COVID-19 in Germany and Poland during the second wave J. Bracher, D. Wolffram, J. Deuschel, K. Görgen, J. L. Ketterer, A. Ullrich, et al. (+111)
582 [GO] 2021―Aug―26 Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS Aartik Sarma, Stephanie A. Christenson, Ashley Byrne, Eran Mick, Angela Oliveira Pisco, Catherine DeVoe, et al. (+110)
583 [GO] 2021―Aug―26 AHR signaling is induced by infection with coronaviruses Federico Giovannoni, Zhaorong Li, Federico Remes-Lenicov, María E. Dávola, Mercedes Elizalde, Ana Paletta, et al. (+8)
584 [GO] 2021―Aug―26 Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum Timothy A. Bates, Hans C. Leier, Zoe L. Lyski, Savannah K. McBride, Felicity J. Coulter, Jules B. Weinstein, et al. (+13)
585 [GO] 2021―Aug―25 Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions Siwy Ling Yang, Louis DeFalco, Danielle E. Anderson, Yu Zhang, Jong Ghut Ashley Aw, Su Ying Lim, et al. (+10)
586 [GO] 2021―Aug―25 A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome Doyeon Kim, Sukjun Kim, Joori Park, Hee Ryung Chang, Jeeyoon Chang, Junhak Ahn, et al. (+9)
587 [GO] 2021―Aug―24 A non-enzymatic, isothermal strand displacement and amplification assay for rapid detection of SARS-CoV-2 RNA Mohsen Mohammadniaei, Ming Zhang, Jon Ashley, Ulf Bech Christensen, Lennart Jan Friis-Hansen, Rasmus Gregersen, et al. (+12)
588 [GO] 2021―Aug―19 The risk of indoor sports and culture events for the transmission of COVID-19 Stefan Moritz, Cornelia Gottschick, Johannes Horn, Mario Popp, Susan Langer, Bianca Klee, et al. (+5)
589 [GO] 2021―Aug―17 High COVID-19 transmission potential associated with re-opening universities can be mitigated with layered interventions Ellen Brooks-Pollock, Hannah Christensen, Adam Trickey, Gibran Hemani, Emily Nixon, Amy C. Thomas, et al. (+5)
590 [GO] 2021―Aug―17 SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters Julia R. Port, Claude Kwe Yinda, Irene Offei Owusu, Myndi Holbrook, Robert Fischer, Trenton Bushmaker, et al. (+6)
591 [GO] 2021―Aug―17 Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery Chengqian Feng, Jingrong Shi, Qinghong Fan, Yaping Wang, Huang Huang, Fengjuan Chen, et al. (+16)
592 [GO] 2021―Aug―17 Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern Donal T. Skelly, Adam C. Harding, Javier Gilbert-Jaramillo, Michael L. Knight, Stephanie Longet, Anthony Brown, et al. (+89)
593 [GO] 2021―Aug―17 A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants Yanyun Du, Rui Shi, Ying Zhang, Xiaomin Duan, Li Li, Jing Zhang, et al. (+16)
594 [GO] 2021―Aug―16 Author Correction: Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom Adam Hampshire, Peter J. Hellyer, Eyal Soreq, Mitul A. Mehta, Konstantinos Ioannidis, William Trender, et al. (+2)
595 [GO] 2021―Aug―12 Author Correction: SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ Ilaria Dorigatti, Enrico Lavezzo, Laura Manuto, Constanze Ciavarella, Monia Pacenti, Caterina Boldrin, et al. (+30)
596 [GO] 2021―Aug―11 Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19 Geraldine Nouailles, Emanuel Wyler, Peter Pennitz, Dylan Postmus, Daria Vladimirova, Julia Kazmierski, et al. (+19)
597 [GO] 2021―Aug―11 Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors Katie L. Kunze, Patrick W. Johnson, Noud van Helmond, Jonathon W. Senefeld, Molly M. Petersen, Stephen A. Klassen, et al. (+38)
598 [GO] 2021―Aug―11 Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase Joseph A. Newman, Alice Douangamath, Setayesh Yadzani, Yuliana Yosaatmadja, Antony Aimon, José Brandão-Neto, et al. (+7)
599 [GO] 2021―Aug―10 Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya George Githinji, Zaydah R. de Laurent, Khadija Said Mohammed, Donwilliams O. Omuoyo, Peter M. Macharia, John M. Morobe, et al. (+20)
600 [GO] 2021―Aug―09 The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients Matthieu Perreau, Madeleine Suffiotti, Pedro Marques-Vidal, Aurelie Wiedemann, Yves Levy, Cédric Laouénan, et al. (+10)
601 [GO] 2021―Aug―09 Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics Shaojuan Zhao, Huajun Zhang, Xinglou Yang, Haiwei Zhang, Ying Chen, Yancheng Zhan, et al. (+11)
602 [GO] 2021―Aug―09 Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York Anthony P. West, Joel O. Wertheim, Jade C. Wang, Tetyana I. Vasylyeva, Jennifer L. Havens, Moinuddin A. Chowdhury, et al. (+14)
603 [GO] 2021―Aug―06 Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses Natalia Ortega, Marta Ribes, Marta Vidal, Rocío Rubio, Ruth Aguilar, Sarah Williams, et al. (+34)
604 [GO] 2021―Aug―06 Structural dynamics of single SARS-CoV-2 pseudoknot molecules reveal topologically distinct conformers Krishna Neupane, Meng Zhao, Aaron Lyons, Sneha Munshi, Sandaru M. Ileperuma, Dustin B. Ritchie, et al. (+3)
605 [GO] 2021―Aug―05 Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan Cesheng Li, Ding Yu, Xiao Wu, Hong Liang, Zhijun Zhou, Yong Xie, et al. (+30)
606 [GO] 2021―Aug―05 COVID-19 spread, detection, and dynamics in Bogota, Colombia Rachid Laajaj, Camilo De Los Rios, Ignacio Sarmiento-Barbieri, Danilo Aristizabal, Eduardo Behrentz, Raquel Bernal, et al. (+14)
607 [GO] 2021―Aug―03 No COVID-19 climate silver lining in the US power sector Max Luke, Priyanshi Somani, Turner Cotterman, Dhruv Suri, Stephen J. Lee
608 [GO] 2021―Aug―03 Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity Shasha Han, Jun Cai, Juan Yang, Juanjuan Zhang, Qianhui Wu, Wen Zheng, et al. (+4)
609 [GO] 2021―Aug―03 Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes Dapeng Sun, Zhe Sang, Yong Joon Kim, Yufei Xiang, Tomer Cohen, Anna K. Belford, et al. (+8)
610 [GO] 2021―Aug―02 SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation Pan Pan, Miaomiao Shen, Zhenyang Yu, Weiwei Ge, Keli Chen, Mingfu Tian, et al. (+16)
611 [GO] 2021―Aug―02 Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia M. De Michele, M. Iacobucci, A. Chistolini, E. Nicolini, F. Pulcinelli, B. Cerbelli, et al. (+9)
612 [GO] 2021―Jul―30 Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress Luiza Mendonça, Andrew Howe, James B. Gilchrist, Yuewen Sheng, Dapeng Sun, Michael L. Knight, et al. (+14)
613 [GO] 2021―Jul―30 A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Martje Fentener van Vlissingen, et al. (+26)
614 [GO] 2021―Jul―30 A fructose/H+ symporter controlled by a LacI-type regulator promotes survival of pandemic Vibrio cholerae in seawater Yutao Liu, Bin Liu, Tingting Xu, Qian Wang, Wendi Li, Jialin Wu, et al. (+7)
615 [GO] 2021―Jul―29 Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection Sara De Biasi, Domenico Lo Tartaro, Lara Gibellini, Annamaria Paolini, Andrew Quong, Carlene Petes, et al. (+20)
616 [GO] 2021―Jul―29 SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection Carolyn A. Cohen, Athena P. Y. Li, Asmaa Hachim, David S. C. Hui, Mike Y. W. Kwan, Owen T. Y. Tsang, et al. (+10)
617 [GO] 2021―Jul―28 IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro Caterina Prelli Bozzo, Rayhane Nchioua, Meta Volcic, Lennart Koepke, Jana Krüger, Desiree Schütz, et al. (+26)
618 [GO] 2021―Jul―27 The trans-omics landscape of COVID-19 Peng Wu, Dongsheng Chen, Wencheng Ding, Ping Wu, Hongyan Hou, Yong Bai, et al. (+64)
619 [GO] 2021―Jul―27 Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization Gita A. Pathak, Kritika Singh, Tyne W. Miller-Fleming, Frank R. Wendt, Nava Ehsan, Kangcheng Hou, et al. (+9)
620 [GO] 2021―Jul―27 Impact of tiered restrictions on human activities and the epidemiology of the second wave of COVID-19 in Italy Mattia Manica, Giorgio Guzzetta, Flavia Riccardo, Antonio Valenti, Piero Poletti, Valentina Marziano, et al. (+14)
621 [GO] 2021―Jul―27 Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets Jeong Seok Lee, June-Young Koh, Kijong Yi, Young-Il Kim, Su-Jin Park, Eun-Ha Kim, et al. (+5)
622 [GO] 2021―Jul―26 Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants Satoshi Ikegame, Mohammed N. A. Siddiquey, Chuan-Tien Hung, Griffin Haas, Luca Brambilla, Kasopefoluwa Y. Oguntuyo, et al. (+8)
623 [GO] 2021―Jul―26 Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’ David S. Fischer, Meshal Ansari, Karolin I. Wagner, Sebastian Jarosch, Yiqi Huang, Christoph H. Mayr, et al. (+24)
624 [GO] 2021―Jul―20 Development and implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities A. Ceci, C. Muñoz-Ballester, A. N. Tegge, K. L. Brown, R. A. Umans, F. M. Michel, et al. (+11)
625 [GO] 2021―Jul―19 SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ Ilaria Dorigatti, Enrico Lavezzo, Laura Manuto, Constanze Ciavarella, Monia Pacenti, Caterina Boldrin, et al. (+30)
626 [GO] 2021―Jul―16 SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance Rémy Robinot, Mathieu Hubert, Guilherme Dias de Melo, Françoise Lazarini, Timothée Bruel, Nikaïa Smith, et al. (+19)
627 [GO] 2021―Jul―16 Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom Adam Hampshire, Peter J. Hellyer, Eyal Soreq, Mitul A. Mehta, Konstantinos Ioannidis, William Trender, et al. (+2)
628 [GO] 2021―Jul―14 Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2 Duane S. Juang, Terry D. Juang, Dawn M. Dudley, Christina M. Newman, Molly A. Accola, William M. Rehrauer, et al. (+3)
629 [GO] 2021―Jul―14 Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity Linh T. Bui, Nichelle I. Winters, Mei-I Chung, Chitra Joseph, Austin J. Gutierrez, Arun C. Habermann, et al. (+69)
630 [GO] 2021―Jul―13 Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance Mohamed Fareh, Wei Zhao, Wenxin Hu, Joshua M. L. Casan, Amit Kumar, Jori Symons, et al. (+8)
631 [GO] 2021―Jul―09 Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2 Qi Zhang, Bin Ju, Jiwan Ge, Jasper Fuk-Woo Chan, Lin Cheng, Ruoke Wang, et al. (+23)
632 [GO] 2021―Jul―07 The molecular basis for SARS-CoV-2 binding to dog ACE2 Zengyuan Zhang, Yanfang Zhang, Kefang Liu, Yan Li, Qiong Lu, Qingling Wang, et al. (+16)
633 [GO] 2021―Jul―07 Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, Yiska Weisblum, Fabian Schmidt, Marina Caskey, et al. (+13)
634 [GO] 2021―Jul―06 Lack of consideration of sex and gender in COVID-19 clinical studies Emer Brady, Mathias Wullum Nielsen, Jens Peter Andersen, Sabine Oertelt-Prigione
635 [GO] 2021―Jul―06 Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan Cesheng Li, Ding Yu, Xiao Wu, Hong Liang, Zhijun Zhou, Yong Xie, et al. (+30)
636 [GO] 2021―Jul―05 Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity L. Vanderbeke, P. Van Mol, Y. Van Herck, F. De Smet, S. Humblet-Baron, K. Martinod, et al. (+49)
637 [GO] 2021―Jul―01 Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape Zhiqiang Ku, Xuping Xie, Edgar Davidson, Xiaohua Ye, Hang Su, Vineet D. Menachery, et al. (+15)
638 [GO] 2021―Jul―01 The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells D. A. Leach, A. Mohr, E. S. Giotis, E. Cil, A. M. Isac, L. L. Yates, et al. (+4)
639 [GO] 2021―Jun―30 SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells Jae Hyung Jung, Min-Seok Rha, Moa Sa, Hee Kyoung Choi, Ji Hoon Jeon, Hyeri Seok, et al. (+5)
640 [GO] 2021―Jun―30 CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2 Donata Hoffmann, Björn Corleis, Susanne Rauch, Nicole Roth, Janine Mühe, Nico Joel Halwe, et al. (+17)
641 [GO] 2021―Jun―28 COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants Pinja Jalkanen, Pekka Kolehmainen, Hanni K. Häkkinen, Moona Huttunen, Paula A. Tähtinen, Rickard Lundberg, et al. (+21)
642 [GO] 2021―Jun―25 Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya Ifedayo M. O. Adetifa, Sophie Uyoga, John N. Gitonga, Daisy Mugo, Mark Otiende, James Nyagwange, et al. (+29)
643 [GO] 2021―Jun―24 The architecture of the SARS-CoV-2 RNA genome inside virion Changchang Cao, Zhaokui Cai, Xia Xiao, Jian Rao, Juan Chen, Naijing Hu, et al. (+8)
644 [GO] 2021―Jun―23 A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry Yanwen Chen, Travis B. Lear, John W. Evankovich, Mads B. Larsen, Bo Lin, Irene Alfaras, et al. (+11)
645 [GO] 2021―Jun―23 COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance Michele Simonetti, Ning Zhang, Luuk Harbers, Maria Grazia Milia, Silvia Brossa, Thi Thu Huong Nguyen, et al. (+7)
646 [GO] 2021―Jun―22 Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation Antonio E. Muruato, Camila R. Fontes-Garfias, Ping Ren, Mariano A. Garcia-Blanco, Vineet D. Menachery, Xuping Xie, Pei-Yong Shi
647 [GO] 2021―Jun―22 Evaluating the climate impact of aviation emission scenarios towards the Paris agreement including COVID-19 effects Volker Grewe, Arvind Gangoli Rao, Tomas Grönstedt, Carlos Xisto, Florian Linke, Joris Melkert, et al. (+6)
648 [GO] 2021―Jun―21 Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Kumari G. Lokugamage, Camila R. Fontes-Garfias, Jing Zou, et al. (+9)
649 [GO] 2021―Jun―21 Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, Nariko Ikemura, Emiko Mihara, Yuhei Kirita, et al. (+12)
650 [GO] 2021―Jun―21 Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain Timothy J. C. Tan, Meng Yuan, Kaylee Kuzelka, Gilberto C. Padron, Jacob R. Beal, Xin Chen, et al. (+7)
651 [GO] 2021―Jun―21 SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals Nils C. Gassen, Jan Papies, Thomas Bajaj, Jackson Emanuel, Frederik Dethloff, Robert Lorenz Chua, et al. (+29)
652 [GO] 2021―Jun―18 Association of social distancing and face mask use with risk of COVID-19 Sohee Kwon, Amit D. Joshi, Chun-Han Lo, David A. Drew, Long H. Nguyen, Chuan-Guo Guo, et al. (+15)
653 [GO] 2021―Jun―18 Emission impacts of China’s solid waste import ban and COVID-19 in the copper supply chain John Ryter, Xinkai Fu, Karan Bhuwalka, Richard Roth, Elsa A. Olivetti
654 [GO] 2021―Jun―18 Community factors and excess mortality in first wave of the COVID-19 pandemic in England Bethan Davies, Brandon L. Parkes, James Bennett, Daniela Fecht, Marta Blangiardo, Majid Ezzati, Paul Elliott
655 [GO] 2021―Jun―18 Immunological imprinting of the antibody response in COVID-19 patients Teresa Aydillo, Alexander Rombauts, Daniel Stadlbauer, Sadaf Aslam, Gabriela Abelenda-Alonso, Alba Escalera, et al. (+5)
656 [GO] 2021―Jun―18 Design of COVID-19 staged alert systems to ensure healthcare capacity with minimal closures Haoxiang Yang, Özge Sürer, Daniel Duque, David P. Morton, Bismark Singh, Spencer J. Fox, et al. (+10)
657 [GO] 2021―Jun―17 Neighborhood-level disparities and subway utilization during the COVID-19 pandemic in New York City Daniel Carrión, Elena Colicino, Nicolo Foppa Pedretti, Kodi B. Arfer, Johnathan Rush, Nicholas DeFelice, Allan C. Just
658 [GO] 2021―Jun―17 Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection Masateru Taniguchi, Shohei Minami, Chikako Ono, Rina Hamajima, Ayumi Morimura, Shigeto Hamaguchi, et al. (+16)
659 [GO] 2021―Jun―17 Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2 Niclas Roxhed, Annika Bendes, Matilda Dale, Cecilia Mattsson, Leo Hanke, Tea Dodig-Crnković, et al. (+15)
660 [GO] 2021―Jun―16 Effect of COVID-19 response policies on walking behavior in US cities Ruth F. Hunter, Leandro Garcia, Thiago Herick de Sa, Belen Zapata-Diomedi, Christopher Millett, James Woodcock, et al. (+2)
661 [GO] 2021―Jun―16 Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers Edurne Rujas, Iga Kucharska, Yong Zi Tan, Samir Benlekbir, Hong Cui, Tiantian Zhao, et al. (+20)
662 [GO] 2021―Jun―16 Modeling the effectiveness of olfactory testing to limit SARS-CoV-2 transmission Daniel B. Larremore, Derek Toomre, Roy Parker
663 [GO] 2021―Jun―16 Controlling the pandemic during the SARS-CoV-2 vaccination rollout João Viana, Christiaan H. van Dorp, Ana Nunes, Manuel C. Gomes, Michiel van Boven, Mirjam E. Kretzschmar, et al. (+2)
664 [GO] 2021―Jun―15 Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease Haixia Su, Sheng Yao, Wenfeng Zhao, Yumin Zhang, Jia Liu, Qiang Shao, et al. (+13)
665 [GO] 2021―Jun―15 Molecular benchmarks of a SARS-CoV-2 epidemic Hakon Jonsson, Olafur T. Magnusson, Pall Melsted, Jonas Berglund, Arna B. Agustsdottir, Berglind Eiríksdottir, et al. (+41)
666 [GO] 2021―Jun―15 Insights into household transmission of SARS-CoV-2 from a population-based serological survey Qifang Bi, Justin Lessler, Isabella Eckerle, Stephen A. Lauer, Laurent Kaiser, Nicolas Vuilleumier, et al. (+68)
667 [GO] 2021―Jun―14 Role of meteorological factors in the transmission of SARS-CoV-2 in the United States Yiqun Ma, Sen Pei, Jeffrey Shaman, Robert Dubrow, Kai Chen
668 [GO] 2021―Jun―14 SARS-CoV-2 infection and transmission in the North American deer mouse Bryan D. Griffin, Mable Chan, Nikesh Tailor, Emelissa J. Mendoza, Anders Leung, Bryce M. Warner, et al. (+22)
669 [GO] 2021―Jun―11 SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, Sailaja Gangadhara, Venkata Viswanadh Edara, Lilin Lai, et al. (+19)
670 [GO] 2021―Jun―11 Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa Ben Morton, Kayla G. Barnes, Catherine Anscombe, Khuzwayo Jere, Prisca Matambo, Jonathan Mandolo, et al. (+59)
671 [GO] 2021―Jun―11 Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records Isobel Routledge, Adrienne Epstein, Saki Takahashi, Owen Janson, Jill Hakim, Elias Duarte, et al. (+21)
672 [GO] 2021―Jun―11 Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States Bingyi Yang, Angkana T. Huang, Bernardo Garcia-Carreras, William E. Hart, Andrea Staid, Matt D. T. Hitchings, et al. (+31)
673 [GO] 2021―Jun―10 Viral infiltration of pancreatic islets in patients with COVID-19 Charlotte Steenblock, Stefanie Richter, Ilona Berger, Marko Barovic, Janine Schmid, Undine Schubert, et al. (+16)
674 [GO] 2021―Jun―09 Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection Bin Yang, Junpeng Fan, Jia Huang, Ensong Guo, Yu Fu, Si Liu, et al. (+16)
675 [GO] 2021―Jun―08 Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination Laura Matrajt, Julia Eaton, Tiffany Leung, Dobromir Dimitrov, Joshua T. Schiffer, David A. Swan, Holly Janes
676 [GO] 2021―Jun―08 A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses Alberto A. Amarilla, Julian D. J. Sng, Rhys Parry, Joshua M. Deerain, James R. Potter, Yin Xiang Setoh, et al. (+25)
677 [GO] 2021―Jun―08 Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1 Jin Chai, Yuanheng Cai, Changxu Pang, Liguo Wang, Sean McSweeney, John Shanklin, Qun Liu
678 [GO] 2021―Jun―08 Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave Matthew M. Hernandez, Ana S. Gonzalez-Reiche, Hala Alshammary, Shelcie Fabre, Zenab Khan, Adriana van De Guchte, et al. (+20)
679 [GO] 2021―Jun―07 SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care Clemens Gutmann, Kaloyan Takov, Sean A. Burnap, Bhawana Singh, Hashim Ali, Konstantinos Theofilatos, et al. (+31)
680 [GO] 2021―Jun―03 Drug repurposing screens identify chemical entities for the development of COVID-19 interventions Malina A. Bakowski, Nathan Beutler, Karen C. Wolff, Melanie G. Kirkpatrick, Emily Chen, Tu-Trinh H. Nguyen, et al. (+26)
681 [GO] 2021―Jun―02 A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2′-O methylation of its first nucleotide Thiruselvam Viswanathan, Anurag Misra, Siu-Hong Chan, Shan Qi, Nan Dai, Shailee Arya, et al. (+2)
682 [GO] 2021―May―31 Impact of COVID-19 outbreaks and interventions on influenza in China and the United States Luzhao Feng, Ting Zhang, Qing Wang, Yiran Xie, Zhibin Peng, Jiandong Zheng, et al. (+7)
683 [GO] 2021―May―27 Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection Arvind Gharbharan, Carlijn C. E. Jordans, Corine GeurtsvanKessel, Jan G. den Hollander, Faiz Karim, Femke P. N. Mollema, et al. (+26)
684 [GO] 2021―May―25 Impacts of social distancing policies on mobility and COVID-19 case growth in the US Gregory A. Wellenius, Swapnil Vispute, Valeria Espinosa, Alex Fabrikant, Thomas C. Tsai, Jonathan Hennessy, et al. (+23)
685 [GO] 2021―May―25 Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq Ramesh Yelagandula, Aleksandr Bykov, Alexander Vogt, Robert Heinen, Ezgi Özkan, Marcus Martin Strobl, et al. (+16)
686 [GO] 2021―May―25 Immune response to SARS-CoV-2 variants of concern in vaccinated individuals Matthias Becker, Alex Dulovic, Daniel Junker, Natalia Ruetalo, Philipp D. Kaiser, Yudi T. Pinilla, et al. (+20)
687 [GO] 2021―May―24 Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives Kangsa Amporndanai, Xiaoli Meng, Weijuan Shang, Zhenmig Jin, Michael Rogers, Yao Zhao, et al. (+6)
688 [GO] 2021―May―21 Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes Kerstin Renner, Tobias Schwittay, Sophia Chaabane, Johanna Gottschling, Christine Müller, Charlotte Tiefenböck, et al. (+19)
689 [GO] 2021―May―21 Peripheral and lung resident memory T cell responses against SARS-CoV-2 Judith Grau-Expósito, Nerea Sánchez-Gaona, Núria Massana, Marina Suppi, Antonio Astorga-Gamaza, David Perea, et al. (+20)
690 [GO] 2021―May―21 Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance Stéphane Le Vu, Gabrielle Jones, François Anna, Thierry Rose, Jean-Baptiste Richard, Sibylle Bernard-Stoecklin, et al. (+17)
691 [GO] 2021―May―20 Controlling COVID-19 via test-trace-quarantine Cliff C. Kerr, Dina Mistry, Robyn M. Stuart, Katherine Rosenfeld, Gregory R. Hart, Rafael C. Núñez, et al. (+11)
692 [GO] 2021―May―19 Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection Ge Song, Wan-ting He, Sean Callaghan, Fabio Anzanello, Deli Huang, James Ricketts, et al. (+15)
693 [GO] 2021―May―18 A rapid, accurate, scalable, and portable testing system for COVID-19 diagnosis Guanhua Xun, Stephan Thomas Lane, Vassily Andrew Petrov, Brandon Elliott Pepa, Huimin Zhao
694 [GO] 2021―May―14 Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, Janneke van’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo, et al. (+88)
695 [GO] 2021―May―14 Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor Jinsung Yang, Simon J. L. Petitjean, Melanie Koehler, Qingrong Zhang, Andra C. Dumitru, Wenzhang Chen, et al. (+4)
696 [GO] 2021―May―14 Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions Xiaopan Gao, Kaixiang Zhu, Bo Qin, Vincent Olieric, Meitian Wang, Sheng Cui
697 [GO] 2021―May―13 Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein Pui Wang, Siu-Ying Lau, Shaofeng Deng, Pin Chen, Bobo Wing-Yee Mok, Anna Jinxia Zhang, et al. (+12)
698 [GO] 2021―May―12 Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic Chirag Modi, Vanessa Böhm, Simone Ferraro, George Stein, Uroš Seljak
699 [GO] 2021―May―12 The epidemicity index of recurrent SARS-CoV-2 infections Lorenzo Mari, Renato Casagrandi, Enrico Bertuzzo, Damiano Pasetto, Stefano Miccoli, Andrea Rinaldo, Marino Gatto
700 [GO] 2021―May―11 Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, Monica Tolazzi, Martina Borghi, Cristina Brigatti, et al. (+14)
701 [GO] 2021―May―11 SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes Irwin Jungreis, Rachel Sealfon, Manolis Kellis
702 [GO] 2021―May―11 A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation Sisi Kang, Mei Yang, Suhua He, Yueming Wang, Xiaoxue Chen, Yao-Qing Chen, et al. (+14)
703 [GO] 2021―May―11 A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes Yu Guo, Lisu Huang, Guangshun Zhang, Yanfeng Yao, He Zhou, Shu Shen, et al. (+42)
704 [GO] 2021―May―10 Predictive performance of international COVID-19 mortality forecasting models Joseph Friedman, Patrick Liu, Christopher E. Troeger, Austin Carter, Robert C. Reiner, Ryan M. Barber, et al. (+7)
705 [GO] 2021―May―10 Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers Stéphane Marot, Isabelle Malet, Valentin Leducq, Karen Zafilaza, Delphine Sterlin, Delphine Planas, et al. (+10)
706 [GO] 2021―May―10 Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features Anastasia Gangaev, Steven L. C. Ketelaars, Olga I. Isaeva, Sanne Patiwael, Anna Dopler, Kelly Hoefakker, et al. (+14)
707 [GO] 2021―May―05 Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, et al. (+6)
708 [GO] 2021―May―04 Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection Bo Diao, Chenhui Wang, Rongshuai Wang, Zeqing Feng, Ji Zhang, Han Yang, et al. (+12)
709 [GO] 2021―Apr―30 Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China Shixiong Hu, Wei Wang, Yan Wang, Maria Litvinova, Kaiwei Luo, Lingshuang Ren, et al. (+23)
710 [GO] 2021―Apr―27 Tracking the global reduction of marine traffic during the COVID-19 pandemic David March, Kristian Metcalfe, Joaquin Tintoré, Brendan J. Godley
711 [GO] 2021―Apr―23 Estimating the effect of social inequalities on the mitigation of COVID-19 across communities in Santiago de Chile Nicolò Gozzi, Michele Tizzoni, Matteo Chinazzi, Leo Ferres, Alessandro Vespignani, Nicola Perra
712 [GO] 2021―Apr―23 COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system Susanne Rysz, Jonathan Al-Saadi, Anna Sjöström, Maria Farm, Francesca Campoccia Jalde, Michael Plattén, et al. (+9)
713 [GO] 2021―Apr―22 Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria Oliver J. Watson, Mervat Alhaffar, Zaki Mehchy, Charles Whittaker, Zack Akil, Nicholas F. Brazeau, et al. (+17)
714 [GO] 2021―Apr―16 Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model Kyle Rosenke, Frederick Hansen, Benjamin Schwarz, Friederike Feldmann, Elaine Haddock, Rebecca Rosenke, et al. (+11)
715 [GO] 2021―Apr―15 Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, Janneke van’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo, et al. (+88)
716 [GO] 2021―Apr―15 Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 Qingrui Huang, Kai Ji, Siyu Tian, Fengze Wang, Baoying Huang, Zhou Tong, et al. (+6)
717 [GO] 2021―Apr―15 The effect of eviction moratoria on the transmission of SARS-CoV-2 Anjalika Nande, Justin Sheen, Emma L. Walters, Brennan Klein, Matteo Chinazzi, Andrei H. Gheorghe, et al. (+9)
718 [GO] 2021―Apr―12 Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions Manon Ragonnet-Cronin, Olivia Boyd, Lily Geidelberg, David Jorgensen, Fabricia F. Nascimento, Igor Siveroni, et al. (+10)
719 [GO] 2021―Apr―09 IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals Michal A. Stanczak, David E. Sanin, Petya Apostolova, Gabriele Nerz, Dimitrios Lampaki, Maike Hofmann, et al. (+7)
720 [GO] 2021―Apr―09 Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany N. Ahmad Aziz, Victor M. Corman, Antje K. C. Echterhoff, Marcel A. Müller, Anja Richter, Antonio Schmandke, et al. (+5)
721 [GO] 2021―Apr―09 GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein Ming Zhao, Yu Yu, Li-Ming Sun, Jia-Qing Xing, Tingting Li, Yunkai Zhu, et al. (+15)
722 [GO] 2021―Apr―08 Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China Shixiong Hu, Wei Wang, Yan Wang, Maria Litvinova, Kaiwei Luo, Lingshuang Ren, et al. (+23)
723 [GO] 2021―Apr―07 A conversation on the effects of the COVID-19 pandemic on academic careers with junior researchers
724 [GO] 2021―Apr―07 A conversation on the effects of the COVID-19 pandemic on junior researchers’ careers with funders and university leaders
725 [GO] 2021―Apr―06 T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses Ane Ogbe, Barbara Kronsteiner, Donal T. Skelly, Matthew Pace, Anthony Brown, Emily Adland, et al. (+55)
726 [GO] 2021―Apr―01 Systems serology detects functionally distinct coronavirus antibody features in children and elderly Kevin J. Selva, Carolien E. van de Sandt, Melissa M. Lemke, Christina Y. Lee, Suzanne K. Shoffner, Brendon Y. Chua, et al. (+35)
727 [GO] 2021―Apr―01 Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV Xiuyuan Ou, Yan Liu, Xiaobo Lei, Pei Li, Dan Mi, Lili Ren, et al. (+12)
728 [GO] 2021―Apr―01 Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, et al. (+6)
729 [GO] 2021―Mar―30 SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself Marta Ferreira-Gomes, Andrey Kruglov, Pawel Durek, Frederik Heinrich, Caroline Tizian, Gitta Anne Heinz, et al. (+36)
730 [GO] 2021―Mar―30 Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial Prasanna Jagannathan, Jason R. Andrews, Hector Bonilla, Haley Hedlin, Karen B. Jacobson, Vidhya Balasubramanian, et al. (+21)
731 [GO] 2021―Mar―29 A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 Alain Townsend, Pramila Rijal, Julie Xiao, Tiong Kit Tan, Kuan-Ying A. Huang, Lisa Schimanski, et al. (+57)
732 [GO] 2021―Mar―29 The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA Jasmine Cubuk, Jhullian J. Alston, J. Jeremías Incicco, Sukrit Singh, Melissa D. Stuchell-Brereton, Michael D. Ward, et al. (+8)
733 [GO] 2021―Mar―29 Implications of the school-household network structure on SARS-CoV-2 transmission under school reopening strategies in England James D. Munday, Katharine Sherratt, Sophie Meakin, Akira Endo, Carl A. B. Pearson, Joel Hellewell, et al. (+7)
734 [GO] 2021―Mar―26 Hospital load and increased COVID-19 related mortality in Israel Hagai Rossman, Tomer Meir, Jonathan Somer, Smadar Shilo, Rom Gutman, Asaf Ben Arie, et al. (+3)
735 [GO] 2021―Mar―26 N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection Dandan Shan, Joseph M. Johnson, Syrena C. Fernandes, Hannah Suib, Soyoon Hwang, Danica Wuelfing, et al. (+19)
736 [GO] 2021―Mar―25 SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition Peter J. Mullen, Gustavo Garcia, Arunima Purkayastha, Nedas Matulionis, Ernst W. Schmid, Milica Momcilovic, et al. (+10)
737 [GO] 2021―Mar―22 SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19 Jun Wu, Boyun Liang, Cunrong Chen, Hua Wang, Yaohui Fang, Shu Shen, et al. (+22)
738 [GO] 2021―Mar―19 An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing Kean Hean Ooi, Mengying Mandy Liu, Jie Wen Douglas Tay, Seok Yee Teo, Pornchai Kaewsapsak, Shengyang Jin, et al. (+8)
739 [GO] 2021―Mar―19 Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection Zhongfang Wang, Xiaoyun Yang, Jiaying Zhong, Yumin Zhou, Zhiqiang Tang, Haibo Zhou, et al. (+9)
740 [GO] 2021―Mar―19 Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Grégory Moureau, Franck Touret, Paul-Rémi Petit, et al. (+8)
741 [GO] 2021―Mar―19 Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection Lukas Wettstein, Tatjana Weil, Carina Conzelmann, Janis A. Müller, Rüdiger Groß, Maximilian Hirschenberger, et al. (+24)
742 [GO] 2021―Mar―17 A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies Chunyan Wang, Rien van Haperen, Javier Gutiérrez-Álvarez, Wentao Li, Nisreen M. A. Okba, Irina Albulescu, et al. (+12)
743 [GO] 2021―Mar―15 SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication Yuchen Zhang, Rui Guo, Sharon H. Kim, Hardik Shah, Shuting Zhang, Jin Hua Liang, et al. (+7)
744 [GO] 2021―Mar―12 Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic Ganna Rozhnova, Christiaan H. van Dorp, Patricia Bruijning-Verhagen, Martin C. J. Bootsma, Janneke H. H. M. van de Wijgert, Marc J. M. Bonten, Mirjam E. Kretzschmar
745 [GO] 2021―Mar―12 Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications Nan Xiao, Meng Nie, Huanhuan Pang, Bohong Wang, Jieli Hu, Xiangjun Meng, et al. (+9)
746 [GO] 2021―Mar―12 SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance Jasmin S. Kutter, Dennis de Meulder, Theo M. Bestebroer, Pascal Lexmond, Ard Mulders, Mathilde Richard, et al. (+2)
747 [GO] 2021―Mar―12 Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions Daniel Butler, Christopher Mozsary, Cem Meydan, Jonathan Foox, Joel Rosiene, Alon Shaiber, et al. (+73)
748 [GO] 2021―Mar―12 Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana Alessio Andronico, Cécile Tran Kiem, Juliette Paireau, Tiphanie Succo, Paolo Bosetti, Noémie Lefrancq, et al. (+7)
749 [GO] 2021―Mar―12 Digital proximity tracing on empirical contact networks for pandemic control G. Cencetti, G. Santin, A. Longa, E. Pigani, A. Barrat, C. Cattuto, et al. (+3)
750 [GO] 2021―Mar―11 Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution Shuyuan Zhang, Shuyuan Qiao, Jinfang Yu, Jianwei Zeng, Sisi Shan, Long Tian, et al. (+3)
751 [GO] 2021―Mar―11 SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface Federico Bertoglio, Doris Meier, Nora Langreder, Stephan Steinke, Ulfert Rand, Luca Simonelli, et al. (+30)
752 [GO] 2021―Mar―10 Author Correction: Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia Supaporn Wacharapluesadee, Chee Wah Tan, Patarapol Maneeorn, Prateep Duengkae, Feng Zhu, Yutthana Joyjinda, et al. (+18)
753 [GO] 2021―Mar―09 The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19 Lander Willem, Steven Abrams, Pieter J. K. Libin, Pietro Coletti, Elise Kuylen, Oana Petrof, et al. (+6)
754 [GO] 2021―Mar―09 Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2 Hanjun Zhao, Kelvin K. W. To, Hoiyan Lam, Xinxin Zhou, Jasper Fuk-Woo Chan, Zheng Peng, et al. (+10)
755 [GO] 2021―Mar―09 Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China Shixiong Hu, Wei Wang, Yan Wang, Maria Litvinova, Kaiwei Luo, Lingshuang Ren, et al. (+23)
756 [GO] 2021―Mar―08 Real-time tracking and prediction of COVID-19 infection using digital proxies of population mobility and mixing Kathy Leung, Joseph T. Wu, Gabriel M. Leung
757 [GO] 2021―Mar―05 Author Correction: Potential health and economic impacts of dexamethasone treatment for patients with COVID-19 Ricardo Águas, Adam Mahdi, Rima Shretta, Peter Horby, Martin Landray, Lisa White
758 [GO] 2021―Mar―05 Deciphering the state of immune silence in fatal COVID-19 patients Pierre Bost, Francesco De Sanctis, Stefania Canè, Stefano Ugel, Katia Donadello, Monica Castellucci, et al. (+18)
759 [GO] 2021―Mar―05 Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP Lukas Bokelmann, Olaf Nickel, Tomislav Maricic, Svante Pääbo, Matthias Meyer, Stephan Borte, Stephan Riesenberg
760 [GO] 2021―Mar―03 A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2 Marie-Ming Aynaud, J. Javier Hernandez, Seda Barutcu, Ulrich Braunschweig, Kin Chan, Joel D. Pearson, et al. (+17)
761 [GO] 2021―Mar―03 Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques Hyon-Xhi Tan, Jennifer A. Juno, Wen Shi Lee, Isaac Barber-Axthelm, Hannah G. Kelly, Kathleen M. Wragg, et al. (+6)
762 [GO] 2021―Mar―02 The prevalence of antibodies to SARS-CoV-2 among blood donors in China Le Chang, Wangheng Hou, Lei Zhao, Yali Zhang, Yanbin Wang, Linfeng Wu, et al. (+21)
763 [GO] 2021―Mar―02 Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques Pragya D. Yadav, Raches Ella, Sanjay Kumar, Dilip R. Patil, Sreelekshmy Mohandas, Anita M. Shete, et al. (+39)
764 [GO] 2021―Mar―01 S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates Joshua G. Liang, Danmei Su, Tian-Zhang Song, Yilan Zeng, Weijin Huang, Jinhua Wu, et al. (+19)
765 [GO] 2021―Feb―26 Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19 Aakriti Gupta, Mahesh V. Madhavan, Timothy J. Poterucha, Ersilia M. DeFilippis, Jessica A. Hennessey, Bjorn Redfors, et al. (+23)
766 [GO] 2021―Feb―26 Orchestrating performance of healthcare networks subjected to the compound events of natural disasters and pandemic Emad M. Hassan, Hussam N. Mahmoud
767 [GO] 2021―Feb―24 Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 Francisco J. Salguero, Andrew D. White, Gillian S. Slack, Susan A. Fotheringham, Kevin R. Bewley, Karen E. Gooch, et al. (+58)
768 [GO] 2021―Feb―22 Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients Juanjie Tang, Supriya Ravichandran, Youri Lee, Gabrielle Grubbs, Elizabeth M. Coyle, Laura Klenow, et al. (+3)
769 [GO] 2021―Feb―20 Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 Adam K. Wheatley, Jennifer A. Juno, Jing J. Wang, Kevin J. Selva, Arnold Reynaldi, Hyon-Xhi Tan, et al. (+16)
770 [GO] 2021―Feb―20 Harnessing peak transmission around symptom onset for non-pharmaceutical intervention and containment of the COVID-19 pandemic Liang Tian, Xuefei Li, Fei Qi, Qian-Yuan Tang, Viola Tang, Jiang Liu, et al. (+6)
771 [GO] 2021―Feb―20 Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity Matthias Becker, Monika Strengert, Daniel Junker, Philipp D. Kaiser, Tobias Kerrinnes, Bjoern Traenkle, et al. (+30)
772 [GO] 2021―Feb―20 Predicting mammalian hosts in which novel coronaviruses can be generated Maya Wardeh, Matthew Baylis, Marcus S. C. Blagrove
773 [GO] 2021―Feb―20 Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections Alan Bénard, Anne Jacobsen, Maximilian Brunner, Christian Krautz, Bettina Klösch, Izabela Swierzy, et al. (+25)
774 [GO] 2021―Feb―19 Reduction in mobility and COVID-19 transmission Pierre Nouvellet, Sangeeta Bhatia, Anne Cori, Kylie E. C. Ainslie, Marc Baguelin, Samir Bhatt, et al. (+45)
775 [GO] 2021―Feb―19 Dysregulated transcriptional responses to SARS-CoV-2 in the periphery Micah T. McClain, Florica J. Constantine, Ricardo Henao, Yiling Liu, Ephraim L. Tsalik, Thomas W. Burke, et al. (+14)
776 [GO] 2021―Feb―19 Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children Melanie R. Neeland, Samantha Bannister, Vanessa Clifford, Kate Dohle, Kim Mulholland, Philip Sutton, et al. (+6)
777 [GO] 2021―Feb―17 Real-time prediction of COVID-19 related mortality using electronic health records Patrick Schwab, Arash Mehrjou, Sonali Parbhoo, Leo Anthony Celi, Jürgen Hetzel, Markus Hofer, et al. (+2)